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ABSTRACT 
Effect of Varying Oxygen Levels on Murine Embryonic Stem Cell Differentiation into 
Endoderm cells 
Nidhi Sheth 
Peter Istvan Lelkes, Ph.D. 
 
 
 Derivation of endoderm lineages from embryonic stem (ES) cells is receiving 
immense attention owing to the need for alternative therapies for debilitating diseases like 
lung cancer, COPD, emphysema, as well as type II diabetes.  Some recent examples are 
derivation of hepatic cells, pancreatic islet-like structures, as well as alveolar cells from 
ES cells, making ES cell research a very exciting field.  However, progress in the field of 
lung tissue engineering and pulmonary regenerative medicine has been fairly slow, 
mainly because of (1) lung’s structural complexity, (2) cellular heterogeneity, and (3) the 
low turnover rate of its epithelia.  In addition, endodermal differentiation efficiency based 
on current approaches is still low, and new methods to improve efficiency should be 
considered.  Stromal cell-to-cell contacts, extracellular matrix proteins, temperature, and 
oxygen (O2) levels in the immediate microenvironment can influence stem cell function 
and differentiation.  Specifically, reduced oxygen tension serves as an important 
physiological and developmental cue for ES cell differentiation.  Low oxygen levels 
(hypoxia) occur in a number of physiological and patho-physiological settings, 
particularly when rapid tissue growth exceeds blood supply.  Embryogenesis occurs in a 
physiologically “hypoxic” environment (3%–8% O2).  Previous studies have shown that 
lung epithelial branching is significantly enhanced under 3% O2, in comparison to 
 
 xvi 
 
ambient air.  Based on these findings, we hypothesized that mimicking the embryonic 
microenvironment will increase endodermal differentiation yield.  At the time of this 
writing, there have been no published papers highlighting the use of reduced oxygen 
tension to enhance murine embryonic stem (mES) cell differentiation towards the 
endoderm.   
 The goal of this project was to derive endoderm cells from mES cells using 
oxygen tension as a modulatory parameter.  ES cell differentiation is accompanied by 
apoptosis upon LIF withdrawal.  In addition, reduced oxygen tension is accompanied by 
an increase in cell death due to an increase in reactive oxygen species (ROS).  Anti-
oxidants like beta-mercaptoethanol (BME) and vitamin-E can act as ROS scavengers, and 
can improve cell survival.  This work was based on the hypothesis that reduced oxygen 
tension and antioxidants enhance mES cell differentiation towards endoderm.  mES cell 
line ES-D3 was cultured under varying oxygen tensions (1%, 3%, 8%, and 21%) in 
medium containing 10% fetal bovine serum (FBS) with or without BME, as well as 5% 
FBS with or without BME for 8 days.  Our results, specific to ES-D3 cells, show that cell 
survival was enhanced in medium containing BME under both ambient (21% O2) and 
reduced oxygen levels (3%, 8%).  Endodermal differentiation markers Sox17 and FoxA2, 
as assessed by quantitative real-time polymerase chain reaction (Q-PCR), showed highest 
differentiation in medium supplemented with 5% serum and 0.1mM BME under 21% O2 
(P < 0.01 as compared to cells differentiated under reduced oxygen tension).  
Immunofluorescence confirmed presence of epithelial-cell marker pan-cytokeratin, as 
well as endothelial cell-marker Griffonia simplicifolia lectin I-isolectinB4, in addition to 
endodermal markers Sox17 and FoxA2.  In contrast to cultures at 21% O2, expression of 
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both endodermal markers decreased as oxygen tension decreased to 3% and 8%.  All 
cells died under 1% O2. 
 In conclusion, this work shows that anti-oxidants enhance cell survival under 
both, normoxic and hypoxic (3% O2) conditions.  Reduced oxygen tension (1%, 3%, and 
8% O2) suppresses endodermal differentiation of ES-D3 cells in serum-supplemented 
medium.  A combination of reduced oxygen tension and anti-oxidants does not enhance 
endodermal differentiation, as compared to normoxic controls. 
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alveolar sacs, and alveoli.  The alveolus serves the respiration and gas exchange function 
of the lung, and is therefore, considered the most essential functional unit of the lung.  An 
adult human male lung is comprised of about 300 million alveoli [3] representing a total 
cross-sectional area of about 75 cm2, approximately 44 times the total surface area of 
human skin [4,5].   
Alveoli are formed to increase the density of gas-exchange surface [6].  Alveolar 
architectural structure is a result of a complex and well-orchestrated interaction among 
pulmonary epithelium, smooth muscle, fibroblasts, and vascular cells (endothelial cells).  
Alveoli are air sacs separated by an extremely thin basement membrane, or alveolar 
septum, and surrounded by elastic fibers and a network of pulmonary capillaries [4].  As 
seen in Figure 1.1-2, this thin basement membrane serves as a gas diffusion barrier 
between pulmonary epithelium and capillary endothelium.  
 
Figure 1.1-2: Exchange surface of alveoli.  The figure above displays the interface at 
alveolar epithelium (air) and pulmonary endothelium (blood) through which gas exchange 
takes place.  Figure adapted from [4].  
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Alveolar septa are formed from the interaction of multiple cell types including 
alveolar epithelium, interstitial fibroblasts, myofibroblasts, smooth muscle and capillaries 
endothelium [7].  Each alveolus is composed of a single layer of epithelium.  Alveolar 
epithelium includes the thin and flat alveolar type I cells (AE1) and the cuboidal alveolar 
type II cells (AE2) [8].  AE1 cells are the predominant cell type in the epithelium, 
covering 95% of the alveolar surface [9,10].  AE1 cells, also known as squamous 
pneumocytes, comprise the thin layer between the air and blood and play a crucial role in 
gas exchange.  While AE1 cells occupy majority of the alveolar surface, AE2 cells, 
which occupy 5% of alveolar surface, predominate alveolar epithelium in terms of cell 
numbers.  In that, AE2 cells are actually twice as numerous as AE1 cells.[8-10]  AE1 and 
AE2 cells occupy 8% and 15% of the total number of lung cells in the body respectively 
[11].  As seen in Figure 1.1-3, AE2 cells are cuboidal in shape, and are generally located 
in the corners of the alveolus [8].  In 1997, Mason and Williams formulated the concept 
of the AE2 cell as the “defender of the alveolus” [12].  AE2 cells produce pulmonary 
surfactant and serve as the stem cell of the alveolar epithelium.  AE2 cells proliferate 
across the alveolus, transdifferentiation into AE1 cells, and remove apoptotic AE2 cells 
by phagocytosis; thus facilitating epithelial repair [12,13]. 
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Figure 1.1-3: Alveolar Structure.  Alveoli are composed of type I cells for gas exchange and 
type II cells that synthesize surfactant.  Alveolar macrophages ingest foreign material that 
reaches the alveoli.  Figure adapted from [4]. 
Interstitial mesenchymal cells include fibroblasts and myofibroblasts.  Fibroblasts 
are ubiquitous mesenchymal cells that possess the ability to proliferate locally, and 
synthesize extracellular matrix (ECM) components like collagen [7].  During wound 
injury, mechanical forces and cellular signaling activate fibroblasts, which migrate to the 
site of injury, proliferate, and synthesize a collagen-containing matrix called granulation 
tissue [14].  Thus, they play an important role in wound healing, by virtue of their ability 
to restore the functional and structural integrity of damaged tissue.  During granulation 
tissue formation, migrating fibroblasts differentiate into myofibroblasts [14,15].  
Myofibroblasts are fibroblasts that express α-smooth muscle actin [15].  In addition, they 
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also express elevated levels of cytokines and extra-cellular matrix, and play a key role in 
inflammation and tissue mechanics.   
Smooth muscle cells allow the regulation of alveolar opening and also provide 
support for the opening.  Capillary endothelium forms the lining of the capillary walls, 
which then interact with the alveoli and facilitate gas exchange [4].  Formation of alveoli 
thus, requires interaction of multiple cell types.  These specialized cell types, that 
constitute the alveolar epithelium in the distal lung, arise from the endodermally derived 
pulmonary epithelium, which is surrounded by mesenchyme of mesodermal origin [16].  
Germ layer interactions between the endoderm and mesoderm are indispensable to distal 
lung development.   
1.2 LUNG PATHOPHYSIOLOGY 
Impairment in distal lung growth leads to many diseases in children as well as 
adults.  Lung disease ranks as the fourth leading cause of death in the world, and the third 
in the United States [17,18].  Almost 400,000 Americans die from lung disease every 
year and this mortality rate is increasing [17].  There are many types of lung diseases and 
most of them are recurrent, chronic, and manifest with multiple symptoms.  One such 
disease is emphysema.  Emphysema, caused by exposure to toxic chemicals including 
tobacco smoke, is associated with an increase in apoptosis of both epithelial and 
endothelial cells of the distal lung [19].  Such a lung is characterized by an irreversible 
enlargement and simplification of alveoli.  These gas-exchange units are lost over time, 
and larger volumes of air need to be inhaled and exhaled to meet the metabolic needs of 
the body.  In addition, these large emphysemic lungs are fixed in a constrained chest 
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cavity, limiting expansion and collapse during breathing, thereby limiting ventilation 
[19].  In chronic conditions, loss of functional alveolar units leads to low blood oxygen 
levels, elevated carbon dioxide levels, and eventually, death.  To compensate for the loss 
of alveolar structure and functionality, the alveolar cells that are not lost to apoptosis are 
programmed to proliferate [20].  During chronic injury, repeated proliferation might be 
required to compensate for lost alveoli.  However, the ability of these cells to proliferate 
is limited because repeated cell cycles induce senescence (aging) [20].  Alveolar 
senescence thus inhibits proliferation, and the lost cells cannot be replaced.  Owing to 
pulmonary destruction and reduction in lung surface area, emphysema shows dismal 
prognosis in regenerating new normal tissue [10,20].   
Another disease, seen especially in neonates, is bronchopulmonary dysplasia 
(BPD), a chronic lung disease associated with premature birth and characterized by early 
lung injury (Figure 1.2-1) [21].  
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Figure 1.2-1: Pathogenesis of Bronchopulmonary Dysplasia (BPD).  Figure adapted from 
[21]. 
As seen in Figure 1.2-1, a variety of prenatal and postnatal factors can contribute 
to the release of “pro-inflammatory and anti-inflammatory” cytokines.  Prenatal factors 
include chorioamnionitis, a condition where inflammation of fetal membranes occurs due 
to bacterial infection.  Postnatal factors include, but are not limited to, ventilator trauma, 
oxygen toxicity, pulmonary edema, as well as sepsis.  An imbalance in these factors leads 
to apoptosis of alveolar epithelium.  Innate responses to BPD include lung repair 
characterized by (1) impaired alveolarization, and (2) dysregulated angiogenesis.  These 
characteristics of BPD lead to a reduction in distal air spaces as well as formation of 
dysmorphic pulmonary vasculature [21].   
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Emphysema and BPD are both distal lung diseases, and have generated interest in 
distal lung repair.  Current approaches to overcome lung pathophysiology are outlined 
below in section 1.3. 
1.3 CURRENT APPROACHES TO COMBAT LUNG DISEASES 
Despite constant attack by molecular pathogens and cytokines, even a non-
regenerating organ like the lung displays capacity to maintain homeostasis post-injury 
[18].  AE2 cells have been known to be stem cells of the adult distal lung [13].  While 
AE2 cells transdifferentiate into AE1 cells during injury [13], the capacity of these cells 
to repair the injured lung is limited during chronic injury1.  Although modern medicinal 
practices can rescue infections and malignancy, the ability to repair damaged tissue or 
organ is less advanced.  Various approaches are currently being used to compensate for 
the limited regenerative potential of the human lung.  Treatment of lung diseases can be 
done by various approaches including drug therapy, oxygen therapy, surgery, pulmonary 
rehabilitation, and mechanical ventilation, but in most cases, the only solution is lung 
transplantation [22].  While solid organ transplantation is a successful treatment option, it 
is fraught with problems like organ rejection, infection, as well as secondary malignancy 
[23].  In addition, there is a severe shortage of donated lungs for transplantation.  Another 
promising therapeutic treatment for restoring lung structure is angiogenic growth factor 
therapy [24].  A recent study reported that recombinant human VEGF treatment of 
newborn rats during or after exposure to hyperoxia, although accompanied by lung 
edema, enhances vessel growth and improves alveolarization [25,26].  However, more 
                                                            
1 For most biomedical scientists and physicians, the term injury refers to damage to cells, tissues, and/or 
organs, at the molecular, physiological, or biochemical level.  Acute lung injury commonly occurs over 
timescales of minute to days, as opposed to chronic injury, that involves persistent pathology over weeks 
or years, depending on the injury stimulus [118].  
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animal and human clinical trials need to be conducted in order to realize the true potential 
of this therapeutic avenue.   
The limited regenerative potential of the distal lung, lack of organ donors, and the 
increasing mortality due to distal lung diseases, indicates an urgent need for clinical 
alternatives in this field [22].  Regenerative medicine, the field devoted to regenerating or 
rebuilding damaged organs from stem cells, provides a promising source to 
repair/regenerate impaired distal lung tissue [23,27]. 
1.4 STEM CELLS FOR LUNG TISSUE ENGINEERING 
Adult and embryonic stem cells are at the core of all current approaches in cell-
based therapies.  Adult stem cells are undifferentiated cells, found among differentiated 
cells in a tissue or organ [23].  These cells can self-renew and differentiate to yield the 
specialized cells of that tissue or organ.  While most adult stem cells are multi-potent and 
lineage-specific, recent evidence shows that there is a certain amount of plasticity even in 
adult stem cells [23].  Since adult stem cells are already specialized, inducement into 
specific cells types can be easier.  In addition, adult stem cells ward off the problem of 
immune rejection, making them a big field in regenerative medicine [23].  In spite of 
their many advantages, tissue specific adult stem cells are limited in quantity and are 
sometimes difficult to obtain in large numbers [23].  Their life cycle is finite, and they 
lose their proliferative capacity over time [23].  In addition, current knowledge regarding 
the regulatory mechanisms governing alveolar turnover due to lung resident adult stem 
cells is limited [11].   
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Adult lung stem cells have been identified to function as stem cells in different 
areas of the lung – for example, basal cells in the conducting airways, Clara cells in the 
conducting airways and bronchioles, AE2 cells in the alveolar epithelium, and lung side 
population cells in the distal lung [11,28].  However, there is no known lung stem cell 
that can give rise to multiple epithelial lineages in both, the proximal and the distal 
airways of the lung.  Therefore, current attempts at lung tissue engineering focus on 
distinct regions of tracheobronchial, bronchiolar, and alveolar epithelium [28].  Our lab 
research is focused on distal lung/ alveolar tissue engineering.   
Embryonic stem (ES) cells are pluripotent cells, isolated from the inner cell mass of 
a blastocyst.  These cells are theoretically immortal, which means that they can be 
maintained indefinitely and expanded as undifferentiated cells.  They can potentially 
provide an endless supply of cells with defined characteristics.  Also, these cells possess 
the ability to differentiate into all three germ layers both in vivo [29]  and in vitro [30], 
namely ectoderm (outermost germ layer), mesoderm (middle germ layer), and endoderm 
(innermost germ layer) (Figure 1.4-1). 
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Figure 1.4-1: The derivatives of the three primary germ layers - ectoderm, mesoderm and 
endoderm - generated during gastrulation.  The ectoderm develops into the skin, nails, the 
epithelium of the nose, mouth and anal canal; the lens of the eye, the retina and the nervous 
system.  The endoderm develops into the inner linings of the digestive tract, as well as the 
linings of the respiratory passages.  It also forms many glands, such as the liver and 
pancreas.  The mesoderm forms the somites, the notochord, and the mesenchyme, which 
give rise to the muscles, circulatory and excretory systems of the body. Figure adapted from 
[31]. 
Lung embryonic development has been studied extensively and developmental 
biologists have identified some of the key signaling pathways, transcription factors, and 
extra cellular molecules found during development, paving the path to lung regeneration. 
However, ES cells have the disadvantage of immunogenicity and tumorigenicity, in 
addition to the ethical and legal issues with their application [32].  While ES cell research 
remains controversial, science continues to bring great advances in understanding stem 
cells at the molecular level.   
Pluripotent murine embryonic stem cell lines have received much attention in the 
research community since successful isolation [33,34] due to the ease of using mouse 
models for implantation and genetic studies.  Understanding lung development, 
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especially embryonic development, is essential for successful directed differentiation of 
ES cells in vitro.  Murine embryonic stem cell line ES-D3 was used for the work in this 
thesis [30]. 
1.5 LUNG DEVELOPMENT 2 
In humans, lung development extends from week 3 of gestation until adulthood.  
Figure 1.5-1 gives an overview of lung development in humans, highlighting the different 
stages of lung development: Embryonic stage (w3-7), Pseudoglandular stage (w7-16), 
Canalicular stage (w16-24), Saccular stage (w24-36), and Alveolar stage (w36-term/ 
adulthood) [35]. 
                                                            
2 In this section, d refers to day, w refers to week, y refers to years, E refers to embryonic day, and PN 
refers to postnatal day. 
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Figure 1.5-1: Human Lung Development.  The anatomical development of the lung can be 
regarded as a continuous process that extends from intrauterine life until adulthood.  
During the pseudoglandular stage, most branching morphogenesis occurs, and the lung has 
a gland-like appearance with epithelial tubules separated by a thick mesenchyme.  During 
the canalicular stage, airway branching is completed, and the mesenchyme becomes 
thinner.  During the saccular stage, the distal lung expands to form saccules, and type I and 
II cells differentiate.  Vascularization (de novo formation of blood vessels) starts in the 
pseudoglandular stage along with branching morphogenesis, and continues until the 
saccular stage of development.  During the alveolar stage, septation of saccules gives rise to 
mature alveoli.  Figure modified from [36]. 
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Figure 1.5-2 compares the stages of lung development in mice and humans.  Lung 
development in mice is divided into five chronological stages, similar to that in humans.  
Lung development in mice ranges from embryonic day (E9.5) to postnatal day 30 
(PN30), whereas human lung development goes on postnatally until 2 years of age, and 
even beyond until adulthood [35]. 
 
Figure 1.5-2: A timeline comparison of lung development in humans and mice.  Displayed 
are the morphological stages and major events in the developing human and mouse lung.  
Although both humans and mice pass through identical phases of lung development, the 
timing for each phase is markedly different between species.  Figure adapted and modified 
from [37]. 
1.6 MURINE EMBRYONIC DEVELOPMENT 
This section discusses murine embryonic development to understand the nature of 
the cells used for the work described in this thesis (murine embryonic stem cells, ES-D3 
line).  In mice, the fertilized egg divides and develops as it travels through the oviduct to 
the uterus.  This process takes about 4-5 days (Figure 1.6-1).  Up to the 8-cell stage of 
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development, all cells are developmentally equal and totipotent (able to give rise to any 
type of cell, embryonic or extra-embryonic).  The process by which blastocyst cells 
acquire their different fates begins at the 8-cell stage with a phenomenon called 
compaction (E3.0).  During compaction, the cells become polarized and tight junctions 
form between them.  With compaction, the cells are now exposed to two different types 
of microenvironments depending on their position within the embryo (E4.0) giving rise to 
a hollow ball of cells.  This phenomenon is called the blastula.  Cells on the outside are 
exposed to the medium surrounding the embryo, and give rise to trophectoderm, while 
cells on the inside that are not exposed to the medium give rise to inner cell mass (ICM) 
[38].  
 
Figure 1.6-1: Development of the pre-implantation embryo in mice from E0.0 to E4.5.  E 
refers to Embryonic day.  Figure adapted from [32]. 
After compaction, the future trophectoderm cells begin to secrete fluid, creating a 
cavity, which will eventually form the blastocoel.  ICM cells in contact with the 
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blastocoel form the primitive endoderm and give rise to the amnion.  The remaining ICM 
consists of undifferentiated cells, commonly referred to as “embryonic stem cells” or 
“pluripotent stem cells”, which give rise to the embryo proper.  POU-domain 
transcription factor OCT4 (also known as OCT3/4 or POU5F1), is essential for 
maintaining the undifferentiated state of ES cells, and is considered a master regulator of 
ES cell pluripotency [39]. 
The ICM develops further into a two-layered structure, containing the epiblast 
adjacent to the amnionic cavity and the hypoblast adjacent to the yolk sac [38,40].  
Pluripotent stem cells are, thus, an in vitro counterpart of a population of cells (epiblast) 
in vivo.  As seen in Figure 1.6-2, the epiblast cells further develop into the three 
embryonic germ layers upon gastrulation.   
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Figure 1.6-2: Scheme of early mouse development depicting the relationship of early cell 
populations to the primary germ layers.  During development, the morula differentiates to 
form a polarized structure consisting of the ICM, and trophectoderm.  Trophectoderm 
forms majority of the placenta, while ICM differentiates into the primitive endoderm and 
primitive ectoderm.  The primitive endoderm can further differentiate into either the 
parietal endoderm or the visceral endoderm.  The primitive ectoderm forms the epiblast, 
which further differentiates into the three embryonic layers: definitive endoderm (More 
information in section 1.5.1), mesoderm, and ectoderm.  Germ cell specification also begins 
in the epiblast during gastrulation.  Figure adapted from [27]. 
Gastrulation is an early phase of development in embryogenesis when massive 
cellular re-organization occurs from a spherical ball of cells, the blastula, into a multi-
layered organism [40].  In the mouse, the beginning of gastrulation is marked by the 
formation of a transient structure known as the primitive streak (PS) in the region of the 
epiblast that will ultimately form the posterior end of the embryo [27,40].  Figure 1.6-3 is 
a pictorial representation of gastrulation in the mouse embryo.   
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Mesendoderm 
Foxa2+, Sox17+, Goosecoid+
Figure 1.6-3: Gastrulation in the mouse embryo.  Prospective endo- and mesodermal cells of 
the epiblast migrate toward the primitive streak and ingress (arrows) through the primitive 
groove to become the definitive endoderm and mesoderm.  The posterior region of the 
primitive streak expresses the marker Brachyury (blue), and the anterior region of the 
primitive streak co-expresses both Brachyury and Foxa2 (red).  At the top of the embryo, 
epiblast cells are shown entering the primitive streak (thick black arrows).  The 
yellow/orange region depicts newly formed mesoderm, and migration of these cells from the 
primitive streak is indicated by thin black arrows.  Also depicted is the movement of the 
earliest definitive endoderm cells (red arrow at bottom).  Although controversial, cells 
expressing Foxa2, Sox17, and Goosecoid are considered definitive endoderm cells.  Figure 
modified from [27]. 
It is likely that a bi-potent cell population, known as the mesendoderm, which has 
the potential to form mesoderm or definitive endoderm, exists within the primitive streak 
[41].  During gastrulation, uncommitted epiblast cells (or what may be “mesendoderm” 
cells) mobilize, ingress through the PS, undergo an epithelial-to-mesenchymal transition 
(EMT), and egress either as mesoderm or as definitive endoderm [27] (See Figure 1.6-3).  
In contrast to mesoderm and definitive endoderm, ectoderm derives from the anterior 
region of the epiblast that does not enter the PS.   
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Different regions of the primitive streak differ in their developmental patterns and 
gene expression.  T-box transcription factor Brachyury (Brachyury T) is a primitive 
streak marker expressed in both the posterior and anterior regions.  Cells that traverse 
through the primitive streak towards the anterior region co-express both Brachyury T and 
Foxa2 [27].  Fox (Forkhead/winged box) proteins, a subgroup of the helix-turn-helix 
proteins, are a family of transcription factors that play key roles in regulating cell growth, 
proliferation, and differentiation.  Foxa2 is expressed in the foregut endoderm in the early 
embryo, and is required for the formation of anterior-posterior axis, and formation of 
endoderm in the mouse embryo [42].  In the mouse embryo, Foxa2 is expressed initially 
in the anterior region of the primitive streak, the site of definitive endoderm induction, 
and subsequently in the endoderm and a number of endoderm-derived tissues including 
the liver, lungs, stomach, and small intestine [40].  Definitive endoderm develops from 
epiblast cells that transit the anterior region of the PS.  Mesendodermal cells, thus, 
exercise a lineage choice between the endoderm and mesoderm in the primitive streak.  
Along with Foxa2, definitive endoderm cells also express Sox17, a well-known 
endoderm marker that is expressed in both definitive and visceral endoderm [43].  Sox17 
is a SRY (Sex Determining Region Y)-related HMG3 box gene that belongs to the Sox-
subgroup F genes, and plays a very important role during development.  A study by 
Kanai-Azuma et al. shows that Sox17 null embryos are deficient of gut endoderm [43].  
This study indicates an important role of Sox17 in endoderm development in the mouse.   
 
3High Mobility Group or HMG is a group of chromosomal proteins that help with transcription, replication, 
recombination, and DNA repair [119]. 
 
P a g e  | 20 
 
However, Foxa2 and Sox17 have been used as important endodermal markers.  
However, endodermal differentiation is a complex process involving a variety of genes, 
and the complete set of markers that distinguish definitive and visceral endoderm have 
not been determined yet. 
DEFINITIVE VERSUS VISCERAL ENDODERM 
Definitive endoderm has been the area of interest for research in the field of tissue 
engineering, because endodermal organs like lung, liver, and pancreas develop from 
definitive endoderm (as seen in Figure 1.6-4 below) that is generated from the anterior 
primitive streak (E7.5 in mice) [38]. 
 
Figure 1.6-4: Representation of definitive endoderm and its derivatives.  The figure shows 
how the definitive endoderm is responsible for deriving the entire gastrointestinal tract and 
lungs; in particular, the portion in the midgut is capable of generating hepatic and 
pancreatic tissue.  Figure adapted from [44]. 
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 Lung epithelium is derived from the endodermal lineage, although the lung 
contains tissue derived from all three germ layers.  In vivo, visceral, and definitive 
endoderm can be distinguished by their position in the embryo.  However, in order to 
mimic the process of endodermal differentiation in vitro, it is necessary to distinguish 
between definitive and visceral endoderm, especially since they share similar molecular 
properties.  Only a few markers differentiate definitive endoderm from visceral 
endoderm4 [45].   
Goosecoid (Gsc), an organizer-specific gene, encodes proteins of the paired (PRD) 
homeobox family of proteins.  In mice, Gsc is expressed briefly during gastrulation in the 
epiblast area where the PS is first formed.  A study by Blum et al. shows that in the 
mouse embryo, Gsc cells are expressed towards the anterior end of the PS, the same 
region that further develops into the definitive endoderm [46].  Yasunaga et al. have 
shown that Gsc is an important marker that helps characterization of definitive endoderm 
versus visceral endoderm [45].  Cells that are definitive endoderm positive express Gsc, 
whereas cells that are visceral endoderm positive do not express Gsc.   
  In addition to Gsc, E-cadherin (ECD) is an important cell-surface receptor that 
distinguishes endoderm from mesoderm [47].  Tada et al. have shown that mesendoderm 
cells diverge to Gsc+ECD+ endoderm and Gsc+ECD- mesoderm precursors5 (See Figure 
1.6-5) [47].  Further, they show that Gsc+ECD+ endoderm precursors differentiate into 
 
4 It should be noted that these studies that aimed to differentiate definitive and visceral endoderm were 
conducted under serum‐free conditions, and under the influence of Activin‐Nodal signaling. More details 
on Activin‐Nodal signaling can be found under Section 1.7.2. 
5 Gsc+ (Goosecoid positive) refers to cells that express goosecoid (Gsc).  ECD‐ (E‐cadherin negative) refers 
to cells that do not express E‐cadherin.  Similar notations have been used for other markers throughout 
the thesis. 
 
P a g e  | 22 
 
definitive endoderm, whereas Gsc+ECD- mesoderm precursors can give rise to 
mesodermal lineages. 
Based on previous pioneering studies in the field [45,47], ECD+Gsc+Sox17+Foxa2+ 
cells represent definitive endoderm, whereas ECD+Gsc-Sox17+Foxa2+ cells represent 
visceral endoderm (See Figure 1.6-5) [45,47].  
 
Figure 1.6-5: The differentiation processes from ES cells to mesendoderm cells. ES cells 
differentiate selectively into the Gsc+ECD+R+ (mesendoderm) intermediates in serum-free 
media containing Activin. Gsc+ECD+R+ intermediates diverge to Gsc+ECD+R- and 
Gsc+ECD-R+ cells, which further differentiate to endoderm and mesoderm cells, 
respectively.  In addition, Gsc-ECD+R- bifurcate from the ES cell without going through an 
intermediate stage to form visceral endoderm.  With this highly selective culture condition 
and surface markers, it is possible to obtain mesendoderm and their progenies without 
using Gsc as a marker.  ECD = E-Cadherin, Gsc = Goosecoid, PDGFR = Platelet Derived 
Growth Factor Receptor, VEGFR = Vascular Endothelial Growth Factor.  Modified and 
adapted from [45, 47, 48]. 
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Figure 1.7-1 for undifferentiated embryonic stem cells).  In the presence of feeder layers, 
mES cells maintained their proliferative, undifferentiated state.  It was reasoned that 
fibroblasts secreted some growth factors that were critical for ES self-renewal [50].  
Later, leukemia inhibitory factor (LIF), an interleukin-6 (IL-6) cytokine produced by 
feeder cells, was identified as a specific differentiation-inhibiting molecule that could 
replace the fibroblast feeder layer in the maintenance of ES cell pluripotency [51].  LIF 
functions through the JAK-STAT pathway [52] in maintaining ES self-renewal.  In the 
absence of LIF, ES cells, by default, differentiate into the neuroectodermal lineage [53].    
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Figure 1.7-2: ES-cell renewal through LIF and other pathways.  LIF activates the pro-self-
renewal JAK-Stat pathway, but also the pro-differentiation Mitogen-activated Protein 
Kinase (MAPK) pathway.  LIF blocks differentiation to the endoderm and mesoderm.  
Bone Morphogenetic Protein (BMP), either exogenous or from serum, activates the MAPK 
pathway and the induction of Id genes that block neurogenesis (ectoderm).  However, BMP 
also induces differentiation into other lineages.  BMP signaling, thus, blocks neurogenesis; 
however, its ability to induce differentiation into other cell types is blocked by LIF/Stat3 
signaling.  LIF alone is insufficient to drive self-renewal as it blocks differentiation of 
mesoderm and endoderm but only weakly blocks differentiation into neuroectoderm.  The 
interplay between LIF and BMP is essential to ES cell self-renewal.  Figure adapted from 
[54]. 
As seen in Figure 1.7-2, LIF binds to its receptor LIFR, and this complex 
activates associated Janus-associated tyrosine kinases (JAK) that phosphorylate the 
receptor chains.  A latent transcription factor STAT3, which contains a key Src homology 
2 (SH2) domain, is phosphorylated by the JAKs, which in turn promote dimerization of 
STAT3.  The STAT3 dimers then translocate to the nucleus where they bind to sites on 
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the DNA that control the transcription of genes important in ES self-renewal.  
Recruitment and activation of STAT3 on engagement of the LIFR blocks endoderm and 
mesoderm differentiation [52,54].   
Binding of LIF to gp130 also stimulates the Ras/mitogen-activated protein kinase 
(MAPK) pathway.  Activation of Ras initiates a cascade of downstream phosphorylations 
that result in the activation of Extracellular Regulated Kinase (ERK).  Activation of ERK 
promotes ectodermal differentiation [52,54].  LIF acts through stat3 to inhibit endodermal 
and mesodermal differentiation, but only weakly blocks ectodermal differentiation.   
In vitro, ES cells are usually maintained in serum containing medium, or serum-
free medium supplemented with bone morphogenetic protein, BMP.  BMP blocks ERK, 
but promotes endodermal and mesodermal differentiation.  However, BMP’s ability to 
induce endodermal/ mesodermal differentiation is blocked by the LIF/Stat3 pathway. 
 Thus, LIF and BMP are both required for self-renewal.  In serum containing 
cultures, LIF is sufficient to maintain self-renewal, as serum might contain BMP.  
However, serum-free cultures need to be supplemented with BMP in addition to LIF, in 
order to maintain pluripotency of ES cells [52,54].   
 LIF withdrawal in the absence of any growth factors promotes spontaneous 
differentiation of ES cells. 
MURINE EMBRYONIC STEM CELL DIFFERENTIATION 
 Activin, a transforming growth factor β (TGF-β) family member, has been used to 
promote endodermal differentiation in mouse [45] and human embryonic stem cells [55].  
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The section below discusses the role of Activin-A in endodermal differentiation of ES 
cells. 
ROLE OF ACTIVIN-A IN ES CELL DIFFERENTIATION TO DEFINITIVE 
ENDODERM 
Activins, disulfide-linked dimers of two β subunits, belong to the TGF-β family 
of growth factors.  Activins act through smads 2, 3, and 4, which directly regulate 
transcription of target genes, such as mesendodermal inducer Brachyury-T [56].  Gadue 
et al. has shown that Activin-A plays a dual role in endodermal induction: (1) to specify 
the primitive streak population and (2) to specify the endoderm from this population.  
Wnt and low levels of Activin-A induce a posterior primitive streak population, whereas 
high levels of Activin-A result in an anterior streak fate [56]. 
Contrary to the above-mentioned premise, a study by Yarmush and colleagues has 
showed that Activin-A, normally an endoderm inducer, caused a dose-dependent 
decrease in endoderm induction, associated with an increase in its precursor epiblast 
population.  On the other hand, follistatin, a known Activin-A inhibitor, increased the 
Foxa2-positive endoderm fraction to 78.4% [57].  Yarmush’s study shows that Activin-A 
suppresses endodermal differentiation, and enhances self-renewal markers, when 
compared to its inhibitor follistatin.  In human embryonic stem cells, Activin-A maintains 
self-renewal in the absence of feeder layers [58].  The role of Activin-A in endodermal 
differentiation of ES cells differs between cell lines, and continues to remain 
controversial. 
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1.8  MIMICKING LUNG MICROENVIRONMENT 
ES cell differentiation is strongly influenced by physical and chemical cues in the 
local extracellular microenvironment like cell-cell interaction, soluble factors, oxygen 
levels, as well as cell culture substrate (natural/synthetic).  For the work described in this 
thesis, we explored the influence of the above-mentioned cues on ES cell differentiation 
by (1) spatially controlling cell-cell interaction (changing seeding density), (2) adding 
soluble factors to the media, (3) culturing ES cells at varying oxygen levels, and (4) 
culturing cells on natural extracellular matrices.  Mimicking lung microenvironments that 
imitate the real environments in which ES cells would function in the body is receiving 
immense attention in distal lung tissue engineering. 
HYPOXIA, LUNG DEVELOPMENT, AND ES CELLS 
 Morriss and New (1970) were the first to demonstrate that the successful 
development of the neural fold by cultured rat embryos in vitro required low oxygen 
levels (5-10% O2) [59].  Morriss and New’s finding formed the basis of all prospective 
cellular research with low oxygen levels.  In 1999, Krasnow and colleagues showed that 
terminal tracheal branching in Drosophila melanogaster is regulated by a particular 
protein, Branchless (orthologue of mammalian fibroblast growth factor [FGF]), in 
oxygen-starved cells.  Low oxygen levels stimulate larval cells to secrete Branchless, 
which attracts new terminal branchless to these cells.  When the branch approaches the 
Branchless expressing cells (oxygen deprived cells), it starts to branch further [60].  
Oxygen levels also play an important role in regulating vascular and pulmonary 
development [61], adipogenesis [62], as well as bone morphogenesis [63].  Of particular 
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interest, in relevance to this thesis, is the role of hypoxia in vascular and pulmonary 
development. 
 Less than 5% O2 is defined as hypoxia.  Physiologic oxygen levels (~3-8%) 
during fetal development are significantly lower than levels in ambient air (~21%) [61].  
At these low, physiologic oxygen levels, numerous genes, and cellular processes are 
activated through hypoxia-sensitive transcription factors (HIFs).  Oxygen availability and 
HIFs play an important role in regulating stem cell behavior [61].  HIFs belong to the 
family of bHLH-PAS (basic-helix-lop-helix-Per-Arnt-Sim) transcription factors, and 
respond to changes in the available oxygen in the cellular microenvironment, specifically 
to decreases in oxygen [64].  HIFs are highly conserved mammalian transcription factors 
that consist of an α subunit (HIF1-α) and a β subunit (HIF1-β).  Mammalian HIF- α 
subunits include HIF-1α HIF-2α, and HIF-3α [61].  HIF-1α is ubiquitously expressed, 
whereas HIF-2α and HIF-3α are restricted to certain tissues [65-67].  HIF-2α is expressed 
primarily in the vasculature of the early developing embryo and subsequently in the lung, 
kidney interstitial cells, liver parenchyma, and neural crest cells [66].  HIF-3α is 
expressed in the thymus, kidney, Purkinje cells of the cerebrum, and corneal epithelium 
of the eye [67]. 
 Particularly, HIF-1α plays a crucial role in lung angiogenesis [68].  Under 
hypoxic conditions, HIF1 activates Vascular Endothelial Growth Factor (VEGF) [69].  In 
mice, vasculogenesis results in the denovo formation of blood vessels from blood islands 
in the lung mesenchyme (E9.0) [69].  Angiogenesis starts around E12.0, when blood 
vessels begin to sprout from the existing pulmonary vascular trunk [24,24].  E12.0 also 
marks the beginning of lung branching morphogenesis in the pseudoglandular stage of 
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embryonic development [37] when a region of the foregut endoderm is induced to invade 
the surrounding mesenchyme.  Lung branching continues until the formation of alveoli in 
the distal lung [37].  Studies of fetal lung explants in vitro suggest that tenascin-C 
mediated lung epithelial branching is enhanced under hypoxic (~3% O2) conditions [70].  
In the lung, hypoxia stimulates mitochondrial production of reactive oxygen species 
(ROS) [71]; this in turn activates HIF-1α, and increases vascular endothelial growth 
factor (VEGF) secretion of AE2 cells [72,73].  VEGF sends signals to its receptor 
VEGFR on the vascular endothelium to promote angiogenesis [72].  Around E14.0, the 
central and peripheral vasculatures connect to establish the vascular network [24].  
Finally, maturation of vasculature overlaps the alveolar stage of lung development.  
Postnatally, immature double-layered capillaries at the gas-exchange interface remodel to 
form single layered structures.  Around the same time, alveolar walls thin and the air-
blood barrier decreases by 20-25% [24].  Studies have suggested that lung branching and 
vascular development are inter-dependent, with the airways providing a template for 
pulmonary artery development [24,69].  Specifically, it appears that low tissue oxygen 
levels in the developing lung enhance the branching of both, distal lung epithelium and 
pulmonary vasculature [69]. The effects of low oxygen levels on ES cells are 
controversial.  Studies have reported that hypoxia enhances stemness in hES cells, and 
also reduced spontaneous differentiation in the undifferentiated state [74,75].  
 Covello and colleagues have shown that HIF-2α regulates expression of Oct-4, 
suggesting its role in maintaining stemness of murine embryos [76].  In a study by 
D’Ippiloto et al. using marrow isolated adult multilineage inducible (MIAMI) cells, low 
oxygen levels inhibited osteogenic differentiation, but promoted stemness [77].  On the 
 
P a g e  | 31 
 
contrary, Bauwens et al. has shown that low levels of oxygen mediate enhancement of 
cardiovascular markers, and thus promotes differentiation of ES cells [78].   
 Some studies have reported that hypoxia promotes stemness and inhibits 
differentiation, while others have reported that hypoxia enhances the differentiation of ES 
cells.  However, at the time of this writing, there is no evidence for the use of hypoxia in 
endodermal differentiation of mES cells (ES-D3 line). 
1.9 ANTI-OXIDANTS IN IMPROVING CELL SURVIVAL 
Mice, cattle, sheep, as well as human embryos have shown higher developmental 
rates when cultured under low oxygen levels [79].  Under low oxygen levels, 
mitochondria release reactive oxygen species (ROS), which eventually leads to oxidative 
stress.  In 1985, Helmut Sies defined ‘oxidative stress’ as “An imbalance between 
oxidants and antioxidants in favour of the oxidants, potentially leading to damage” [80].  
Oxidants or reactive oxygen species (ROS) like hydrogen peroxide, superoxide anions, 
and hydroxyl radicals are produced as a part of aerobic metabolism.  In vivo, thiols like 
glutathione (r-glutamylcysteinylglycine) act as anti-oxidants, scavenge ROS, and enable 
maintenance of quasi steady-state equilibrium [79,80].   
A study by Takahashi et al. demonstrated that the addition of low molecular 
weight thiols such as cysteamine and β-mercaptoethanol (BME) to culture medium 
enhanced the production of 6- to 8-cell bovine embryos in vitro.  Another study by 
Watanabe and colleagues reported that the developmental potential of porcine oocytes is 
enhanced in the presence of anti-oxidants [79].  The resulting increase in developmental 
ability was concluded by observing a greater number of cells developing to the blastocyst 
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stage, less hydrogen peroxide per embryo, and reduced DNA fragmentation.  Thus, anti-
oxidants enhance the developmental ability of cells/ embryos.   
Cellular differentiation at ambient air is also accompanied by ROS production, 
since LIF withdrawal causes 30% of the cells to undergo apoptosis, and the remaining 
70% to either proliferate/differentiate [81].  Based on this, we hypothesized that anti-
oxidants would promote cell survival under differentiation conditions.  For the purpose of 
this thesis, anti-oxidant β-mercaptoethanol was utilized to reduce oxidative stress in 
cultured cells.  
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CHAPTER 2: DESIGN COMPONENT 
2.1 IDENTIFICATION OF THE PROBLEM 
Derivation of endoderm lineages from embryonic stem cells is receiving immense 
attention due to the need of alternative therapies for debilitating diseases like lung cancer, 
COPD, emphysema, as well as type II diabetes [32].  Some recent examples are 
derivation of hepatic cells [82] and pancreatic islet-like structures [83], as well as alveolar 
cells [84], making this a very exciting field.  However, progress in the field of pulmonary 
regenerative medicine has been slow, mainly because of (1) lung’s structural complexity, 
(2) cellular heterogeneity, and (3) the low turnover rate of its epithelia [85].  In addition, 
endodermal differentiation efficiency is still low, and new methods to improve efficiency 
should be considered [85].  Stromal cell-to-cell contacts, extracellular matrix proteins, 
temperature, and oxygen (O2) levels in the immediate microenvironment can influence 
stem cell function and differentiation [61].  Specifically, reduced oxygen tension serves 
as an important physiological and developmental cue for ES cell differentiation.  Low 
oxygen levels (hypoxia) occur in a number of physiological and patho-physiological 
settings, particularly when rapid tissue growth exceeds blood supply [61].  
Embryogenesis occurs in a physiologic “hypoxic” environment (3%–8% O2)[70]  
Previous studies have shown that lung epithelial branching is significantly enhanced 
under 3% O2, in comparison to ambient air  [70].  We hypothesized that mimicking the 
embryonic microenvironment will increase endodermal differentiation yield.  At the time 
of this writing, there have been no published papers highlighting the use of reduced 
oxygen tension as a modulatory parameter to enhance murine embryonic stem cell (mES) 
differentiation towards the endoderm.   
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2.2 GOAL 
The long-term goal of our lab is to provide an expandable, alternative endoderm 
cell source for therapeutic applications in lung tissue engineering and pulmonary 
regenerative medicine.  The goal of this project was to optimize differentiation of murine 
embryonic stem cells into endoderm cells using reduced oxygen tension as a modulatory 
parameter.  
2.3 HYPOTHESIS 
Reduced oxygen tension and anti-oxidants enhance murine embryonic stem cell 
differentiation towards the endoderm lineage. 
2.4 DESIGN OBJECTIVES/ SPECIFIC AIMS 
This thesis work was broken down into three measureable specific aims, as stated below: 
Aim 1: To optimize two-dimensional (2D) seeding density of murine embryonic stem 
cells (ES-D3), in establishing appropriate conditions for differentiation into endoderm 
cells. 
Aim 2: To optimize the cell culture medium for ES-D3 differentiation into endoderm 
cells. 
Aim 3: To investigate the effects of varying oxygen tension on ES-D3 differentiation 
into endoderm cells.  
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AIM 1: TO OPTIMIZE TWO-DIMENSIONAL (2D) SEEDING DENSITY OF 
MURINE EMBRYONIC STEM CELLS (ES-D3), IN ESTABLISHING 
APPROPRIATE CONDITIONS FOR DIFFERENTIATION INTO 
ENDODERM CELLS. 
Specific Aim 1 assessed the effects of different ES-D3 cellular seeding densities 
on ES-D3 growth.   
RATIONALE 
Optimizing cell seeding protocols and densities is extremely important to ensure 
good cell attachment and growth.  Sufficient cell density and initiation of gene activity 
are permissive factors essential for appropriate cell commitment [86].  McBride et al. 
have shown that cell-seeding density influences mesenchymal stem cell shape and fate 
[86].  Different ECM substrates and growth media along with initial cell seeding density 
have an impact on differentiation.  Previous experiments have shown that a low seeding 
density of murine embryonic stem cells promotes endodermal differentiation [45,84].  
However, the cell lines and culture media used in these experiments were different from 
the ones used for our experiments.  For this reason, it was essential to optimize the 
seeding density appropriate for endodermal differentiation, specific to our culture 
conditions.  Trypan blue staining was performed to get quantitative results about fold 
increase in cell number.  However, Trypan blue staining, although a simple way to 
evaluate cell membrane integrity (and thus assume cell proliferation or death), is not 
sensitive and cannot be adapted for high-throughput screening.  Therefore, Alamar blue 
assay was used to endorse results from trypan blue staining.  Intrinsic proliferation 
profiles were compared for two different media supplemented with or without β-
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Optimize ES‐D3 
Seeding Density
DMEM 10% FBS
with 0.1mM BME
(6.25K, 12.5K, 25K, 50K)
Cell Counting
Proliferation 
Assay
Morphology
DMEM 10% FBS 
w/o BME
(6.25K, 9K, 25K, 50K)
Cell Counting
Proliferation 
Assay
Morphology
 
Figure 2.4-2: Schematic of experimental design for specific aim 1.  Seeding density was 
optimized for two different media, supplemented with and without β-mercaptoethanol 
(BME).  DMEM = Dulbecco’s Minimum Essential Medium.  FBS = Fetal Bovine Serum 
DESIGN CRITERIA 
Optimum seeding density should satisfy the following design criterion:  
Table 2.4-1: Design Criteria for Specific Aim 1 
Criterion Rationale 
 
1. Allow for cell 
expansion for 6-8 
days without 
passaging. 
 
Previous experiments in our lab have shown that definitive 
endoderm expression peaks on Day 6 [84].  For the scope of 
this project, all experiments were run for a minimum of 6 to 
a maximum of 8 days.  Therefore, it is essential that cells do 
not become confluent and that there is sufficient space to 
allow for cell spreading. 
 
CONSTRAINTS 
Seeding conditions needed to be optimized under normoxic conditions (21% O2), 
even though the ultimate aim was to differentiate cells under reduced oxygen tension.  
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This was because the chamber to be used to maintaining reduced oxygen tension, the 
Ruskinn Invivo2300; (to be used for the final experiments) was not available at the time 
of this experiment (See Figure 3.2-1 for a picture of the hypoxia chamber).   
ALTERNATIVE SOLUTIONS 
An alternative way of measuring cellular proliferation is the MTT assay.  MTT 
assay is a cell viability assay and involves transformation of tetrazolium salt by 
mitrochondrial succinic dehydrogenases in viable cells, yielding purple formazan crystals 
that are not soluble in aqueous solution  [88].  While both the MTT and alamarBlue 
assays test for cell viability, alamar blue assay is more homogenous and sensitive, in that 
it can detect cell densities as low as 200cells/well.  In addition, alamarBlue is non-toxic, 
does not harm the cells, and enables use of the same cells for subsequent functional 
assays.  MTT, on the other hand, involves cell lysis, and so subsequent assays cannot be 
performed.  Considering the advantages of alamarBlue over MTT, alamarBlue assay was 
chosen to measure cell viability [88]. 
AIM 2: TO OPTIMIZE THE CELL CULTURE MEDIUM FOR ES-D3 
DIFFERENTIATION INTO ENDODERM CELLS. 
 The objective of specific aim 2 was to determine the optimum environment for ES 
cell differentiation into the endoderm by varying differentiating factors like fetal bovine 
serum, Activin-A, and conditioned medium.   
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RATIONALE 
Embryonic stem cells are very sensitive to culture conditions, including pH, 
temperature, humidity, as well as the growth factors and medium used for differentiation 
[89].  Every cell type has a unique microenvironment consisting of proliferative and 
differentiative cues that influence cell fate decisions [35].  Soluble factors like serum, 
anti-oxidants, and growth factors have a profound effect on cellular differentiation [90].  
Different cell lines might respond differently to these factors in the microenvironment.  
Therefore, it was essential to find out the appropriate mixture of soluble cues in liquid 
media for the in vitro differentiation of our specific cell line.  This specific aim was 
divided into two parts. 
Two different media (with or without BME) were supplemented with two 
different soluble factors (1) varying concentrations of fetal bovine serum and/or (2) 
Activin-A.  Serum supplementation for cell culture is an established standard, and 
provides for necessary nutrition, growth factors, and cytokines [91].  However, serum 
composition remains unknown, and the concentration of growth factors varies from batch 
to batch [90].  In addition, unknown serum components might interfere with cell-cell 
signaling, and hence differentiation.  Regulatory authorities, industry, and the entire 
research community encourage use of serum-free alternatives because of undefined 
composition, risk of contaminations, and animal welfare considerations concerning the 
production of sera [91].  In addressing these issues, we attempted use of serum-free/ 
serum-replacement alternatives in our preliminary experiments (Appendix A).  However, 
our cells (ES-D3) did not survive in 100% serum-free/ serum-replacement conditions, 
prompting us to evaluate the effect of decreasing serum concentration for our cell culture.  
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We hypothesized that decreasing serum concentrations might enhance ES-D3 
endodermal differentiation. 
Previous studies have shown that Activin-A enhances endodermal differentiation.  
However, these studies utilized serum-free formulations and a transformed cell lines for 
their experiments [45,47,92,93].  Recently, Yarmush and colleagues have shown that 
follistatin, an Activin-A inhibitor enhances endodermal differentiation in ES-D3 cells 
(the same cell source used for this thesis work) [57].  Therefore, it was important to test if 
Activin enhances or inhibits endodermal differentiation for our culture conditions.  
A549 cell line was initiated in 1972 by D.J. Giard, et al. through explant culture 
of lung carcinomatous (adenocarcinoma) tissue from a 58-year-old Caucasian male [94].  
Studies by Roszell et al. using the mES cell line, E14, have shown that conditioned 
medium from A549 cells derives a higher yield of definitive endoderm than Activin-A 
alone [84].  Using mES cells, Rippon et al. have A549 conditioned medium promotes 
production of well-differentiated AE2 cells containing lamellar bodies, apical microvilli, 
and surfactant protein C [95].  Evidence from these studies prompted us to investigate the 
effect of A549 conditioned medium on endodermal differentiation of ES-D3 cells.  
EXPERIMENTAL DESIGN 
Specific Aim 2 was divided into two sub-aims: Aim 2A for experiments with medium 
containing BME, and Aim 2B for experiments with medium without BME.  Figures 2.4-
3, 2.4-4, and 2.4-5 display a schematic/ abridged experimental design for specific aims 2, 
2A, and 2B respectively. 
 
 | 41 P a g e
 
F
op
A
F
 
 
igure 2.4-3: 
timized for 
IM 2A: ME
igure 2.4-4: 
Schematic 
two differen
DIUM CO
Schematic re
representatio
t base media
NTAINING
presentation
n for Speci
, supplemen
 BME 
 
 of Specific 
fic Aim 2.  
ted with and
Aim 2A. 
 
Differentiat
 without BM
 
ion medium
E. 
 was 
 
 | 42 
 
A
F
 
 
 
 
 
 
 
 
 
 
IM 2B: ME
igure 2.4-5: 
DIUM WIT
Schematic R
HOUT BM
epresentatio
E  
n for Specific Aim 2B. 
P a g e
 
 
P a g e  | 43 
 
DESIGN CRITERIA 
Optimum differentiation medium satisfy the following design criteria: 
Table 2.4-2: Design Criteria for Specific Aim 2 
Criterion Rationale 
 
1. Display 
cobblestone-like 
epithelial cell 
morphology.  
 
 
Embryonic cells show epithelial like morphology upon 
differentiation to endoderm cells [57].  Representative 
picture, Scale = 100 µm 
 
 
 
2. Yield a 
polymerase 
chain reaction 
cycle threshold 
value between 8 
– 35, for a total 
of 40 cycles run.  
 
 
Cutoff values suggested for the StepOne Real time PCR 
system by Applied Biosystems.  Any value outside this 
range for a particular marker of interest would mean there 
is no mRNA expression for that marker. 
 
 
CONSTRAINTS 
One constraint was that the Applied Biosystems Step One Real-Time PCR system 
(48 well) had to be used for this study.  If a 96 well plate machine were available, PCR 
assays and analysis would have been more time and energy efficient.  
ALTERNATIVE SOLUTIONS 
 Fluorescence-activated cell sorting (FACS) is a specialized type of flow 
cytometry.  It provides a method for sorting a heterogeneous mixture of biological cells 
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into two or more containers, one cell at a time, based upon the specific light scattering 
and fluorescent characteristics of each cell [96].  Individual cells traveling in single file in 
a fine stream pass through a laser beam and the fluorescence of each cell is measured.  It 
is possible to sort different cells with different gene markers using this fast, objective, and 
quantitative method [96].  FACS is more sensitive and accurate, and can provide the 
percentage of cells expressing a certain gene product, as opposed to quantitative fold 
increase in mRNA expression from Q-PCR [96].  In our experiments, Q-PCR was used 
due to lack of access to a FACS machine. 
AIM 3: TO INVESTIGATE THE EFFECTS OF VARYING OXYGEN TENSION 
ON ES-D3 DIFFERENTIATION INTO ENDODERM CELLS.   
RATIONALE 
 The ambient environment in the conventional laboratory incubator (~21% O2) 
does not reflect the embryonic oxygen tension in vivo (2-8 %).  Studies have shown that 
lung epithelial branching morphogenesis is enhanced under fetal oxygen levels (3% O2) 
[68,70].  Based on this, we hypothesized that reduced oxygen tension (≤ 2 - 8 % O2) will 
significantly accelerate and enhance mES differentiation. 
EXPERIMENTAL DESIGN 
For specific aim 3, oxygen tension was varied between 1 – 21% O2 as seen in 
Figure 13.  Gene expression was evaluated at the mRNA and protein levels for markers 
Oct4 (marker for pluripotency), and endodermal markers Foxa2, and Sox17.  In addition, 
we wanted to test if reduced oxygen tension promotes differentiation into endothelial/ 
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DESIGN CRITERIA 
Differentiation under optimum oxygen levels should satisfy the following design criteria: 
Table 2.4-3: Design Criteria for Specific Aim 3 
Criterion Rationale 
 
1. Display 
cobblestone-like 
epithelial cell 
morphology.  
 
 
Embryonic cells show epithelial like morphology upon 
differentiation to endoderm cells [57].  Representative 
picture, Scale = 100 µm 
 
 
 
2. Yield a 
polymerase 
chain reaction 
cycle threshold 
value between 8 
and 35, for 40 
cycles that 
should be run.  
 
 
Cutoff values suggested for the StepOne Real time PCR 
system by Applied Biosystems.  Any value outside this 
range for a particular marker of interest would mean there 
is no mRNA expression for that marker. 
 
 
3. Expression of 
immunomarkers 
FoxA2 and 
Sox17. 
 
 
Immunostaining of these markers would confirm 
endodermal expression at the protein level. 
 
 
 
 
 
 
 
P a g e  | 47 
 
CONSTRAINTS 
The Ruskinn Invivo2300 (hypoxia chamber) (See Figure 3.2-1) used for these 
experiments, was available only for a month and a half before the completion of this 
thesis work.  Because of this, time was a major constraint with the experiments from this 
specific aim. 
ALTERNATIVE SOLUTIONS 
  An alternative solution was to use the Coy Hypoxic Glove Box and Cabinet (See 
Figure 3.2-2).  However, as this chamber was run only at 1% O2, the Ruskinn Invivo2300 
had to be used for these experiments, and the experiments had to be performed and 
completed in a short period.  
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CHAPTER 3: MATERIALS AND METHODS 
3.1 MATERIALS 
Dulbecco’s Modified Eagle’s Medium high glucose (4.5g/L), Penicillin- 
Streptomycin, Trypsin, Tissue Culture Grade water, Dulbecco’s Phosphate Buffered 
Saline (without calcium and magnesium), Bovine Serum Albumin, Triton-X, and 
Bizbenzimide were purchased from Fisher Scientific (Pittsburgh, PA).  ESGRO® was 
purchased from Chemicon (Dundee, UK).  Fetal bovine serum was purchased from 
Cellgro (Mediatech, Inc.).  Rabbit polyclonal anti-Oct-4 was purchased from ABCAM, 
whereas rabbit polyclonal anti-Sox17, and rabbit polyclonal FoxA2 were purchased from 
Millipore.  Gibco™ Knockout™ Serum Replacement, StemPro® Accutase® Cell 
Dissociation Reagent, secondary Antibody conjugated to Alexafluor 488 (Chicken anti-
rabbit), normal chicken serum, pan-cytokeratin, and human plasma fibronectin were 
purchased from Molecular Probes™, Invitrogen (Eugene, OR, USA).  All primers for Q-
PCR (see Table 5), high capacity cDNA synthesis kit, and TaqMan(R) Fast Universal 
PCR Master Mix were purchased from Applied Biosystems.  Activin-A was purchased 
from R&D Systems (Minneapolis, MN).  Rat tail Collagen Type I (mouse) was 
purchased from BD Biosciences. Griffonia simplicifolia lectin I-isolectinB4 (isoB4) and 
Texas Red Avidin D were purchased from Vector Laboratories.  All other reagents 
purchased from commercial sources were of analytical grade. 
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3.2 METHODS 
CELL MAINTENANCE 
ES-D3 MAINTENANCE 
Murine embryonic stem cells (mES), D3 ES cells derived from 129/Sv day-4 
blastocysts in 1985 by Doetschmann et al., were utilized for all experiments [30].  
Undifferentiated mouse D3 ES cells (American Type Culture Collection (ATCC®) 
Catalog Number CRL-1934) were cultured on 0.1% gelatin-coated 25 cm2 tissue culture 
(T25) flasks, at low dilutions of 1:6, such that small colonies were maintained.  Medium 
was changed daily.  Cells were passaged6 every 2-3 days.  Undifferentiated mES cells 
were cultured in ES- Maintenance Medium (ES-MM) consisting of high-glucose 
Dulbecco's modified Eagle's medium (DMEM) (4.5 g/L) supplemented with 10% fetal 
bovine serum, 0.5% penicillin/ streptomycin (100 U/ml), ESGRO (1,000 U/ml), and 2-
mercaptoethanol (0.1 mM).  Proliferating ES cell cultures were maintained in a 5% CO2-
humidified incubator at 37°C at ambient oxygen pressure. 
A new vial was purchased from ATCC, and the cells from this vial were 
considered as passage 1 (P1).  Cells at passage 3 (P3) were expanded until P5, and were 
stored at -80°C in ES-MM supplemented with 10% DMSO until use.  One more passage 
was allowed after storage such that all trials were at P7.   
 
                                                            
6 In cell culture, the process by which cells are disassociated, washed, centrifuged, and seeded into new 
culture plates after a round of cell growth and proliferation is defined as a passage.  Passage number 
refers to the number of times a culture has been subcultured, and is, thus, indicative of the age of the line 
of cultured cells.   
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A549 MAINTENANCE AND CONDITIONED MEDIUM 
A549 cell line was initiated in 1972 by D.J. Giard, et al. through explant culture 
of lung carcinomatous (adenocarcinoma) tissue from a 58-year-old Caucasian male [94].  
A549 cells (ATCC® Catalog Number CCL-185), were maintained in a high glucose 
DMEM (GIBCO) supplemented with 10% FBS.  Once the cells reached confluence, the 
medium was changed to serum-free DMEM medium for 24 hours.  This “conditioned” 
medium was collected and filtered through a 0.2 μm filter and stored at 4°C until needed.  
Approximately 13 ml of medium was conditioned per T-75 flask, as needed. 
PLATING ES-D3 CELLS ON A MIXTURE OF COLLAGEN TYPE I AND 
FIBRONECTIN 
Previous experiments in our lab have shown that a mixture of collagen type I 
(0.1mg/ml) and fibronectin (0.01mg/ml) show higher endodermal differentiation, as 
compared to collagen type I only, collagen type IV only, collagen type IV along with 
fibronectin, fibronectin only, and gelatin (See Appendix B for details). 
Therefore, a mixture of collagen type I (0.1mg/ml) and fibronectin (0.01mg/ml) 
was used for coating the wells.  3.8 µg of protein was coated per well of a tissue culture 
12-well plate (1 µg/cm2) [57].  Type I collagen solution was prepared by diluting 
collagen stock (4.59mg/ml) to 1mg/ml in 0.02N acetic acid.  Collagen solution at 1mg/ml 
was further diluted to a final concentration of 0.1 mg/ml in phosphate-buffered saline 
(PBS).  Human plasma fibronectin (1mg/ml) was diluted in the collagen-PBS mixture to 
a final concentration of 0.01mg/ml.  The tissue culture plates were incubated for 1 hour at 
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37°C to ensure protein attachment on the surface.  Excess protein was aspirated after 1 
hour, and the plates were washed with 1X PBS without calcium magnesium.  
ES-D3 CELL DIFFERENTIATION 
All experiments were carried out in 12-well plates.  One day prior to the 
experiment, ES cells in ES-MM were switched to a serum replacement medium (SF-
MM) containing Knockout-DMEM, 15% Knockout Serum Replacement, 0.5% penicillin/ 
streptomycin (100 U/ml), 0.1 mM non-essential acids, 2 mM L-glutamine, 10 μM 2-
mercaptoethanol, and ESGRO (1,000 U/ml).   
Prior to the actual experiment, media was aspirated and the culture was gently 
washed with pre-warmed (37°C) phosphate buffered saline (PBS) to remove any 
unattached cells, and then incubated with 1mL of Accutase (Invitrogen) for 1 min or until 
all cells were visibly detached.  The advantages of Accutase over the traditional 
Trypsin/EDTA treatment are that it is less damaging to cells leading to increased viability 
and carries a lower risk of introducing adventitious agents into cell cultures because it 
does not contain any mammalian or bacterially derived proteins. 
9 mL of serum containing medium was added per flask to stop the reaction.  The 
suspension was vigorously pipetted to sever any remaining connections and create a 
homogenous, single-cell suspension.  Cells were then centrifuged (800rpm, 5 minutes), 
the supernatant was discarded, and the cells were resuspended in 5-6mL of differentiating 
medium (with or without BME).    
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2mL of differentiation medium was added per well, and the plates were incubated 
at 37°C prior to seeding.  Basal differentiation medium consisted of high-glucose DMEM 
supplemented with 0.5% penicillin/streptomycin.  For serum concentration studies, 
medium was supplemented with 10%, 5%, or 2% fetal bovine serum (FBS).  For soluble 
factor studies, the serum-supplemented medium was further augmented with BME 
(0.1mM) and/or Activin-A (20ng/ml).  For differentiation using A549 conditioned 
medium, filtered conditioned medium was mixed 50/50 (v/v) with DMEM 10% FBS 
supplemented with or without BME, such that the final serum concentration was 5%.   
  For differentiation studies, both under ambient (21% O2) and reduced oxygen 
levels (1%, 3%, or 8% O2), cells were plated at densities of 10000 cells/well for medium 
containing BME, and 20000 cells/well for medium without BME.  These seeding 
densities were picked as optimum7, such that they allowed for cell differentiation for a 
maximum of 8 days, without passaging.  Medium was changed every 2 days of culture.  
Prior to medium change, the cells were washed gently with pre-warmed PBS to get rid of 
any dead or floating cells.  Plates were returned to the incubator until the next time point.  
For studies at ambient oxygen levels, differentiating ES cultures were maintained in a 5% 
CO2-humidified incubator at 37°C for a total of 6 – 8 days, depending on the duration of 
the study.   
For studies at reduced oxygen levels of 3% or 8% O2, differentiating ES cultures 
were maintained in a humidified controlled chamber as seen in Figure 3.2-1 (Ruskinn 
Invivo2 300, Ruskinn Technology Limited, Bridgend, UK) at the following settings: 3 or 
8 % O2 and 5% CO2.  For studies at 1% O2, differentiating ES cultures were maintained 
 
7 Optimum refers to the most favorable condition, amongst the range of conditions tested. 
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in a humidified controlled chamber as seen in Figure 3.2-2 (Coy Hypoxic Glove Box and 
Cabinet, Coy Laboratory Products, Inc., Michigan, United States) at 1% O2 and 5% CO2.  
Media/ 1X PBS were let to equilibrate overnight (8-12 hours) in tissue-culture vent 
capped T-25 or T-75 flasks, and used subsequently for media change.  For RNA 
harvesting (for Q-PCR), the media was aspirated, the wells washed with ice-cold PBS, 
and Trizol (maintained cold on ice) was added to the appropriate wells prior to removal 
of plates.  Similarly, for cellular fixation (for immunofluorescence), the media was 
aspirated, the wells washed with PBS, and para-formaldehyde was added to the 
appropriate wells prior to removal of plates.  This ensured that gene /gene-product 
expression would not change upon exposure to normoxic conditions. 
 
Figure 3.2-1: Ruskinn Invivo2 300 Hypoxic Workstation.  Figure adapted from [97].   
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Figure 3.2-2: Coy Laboratory Hypoxic Glove Box.   
During culture, cells were examined daily under an inverted light microscope.  At 
each time point, cells were sampled in order to detect endoderm cells by (a) phase-
contrast microscopy, (b) immunofluorescence, and (c) quantitative real time polymerase 
chain reaction (Q-PCR), as outlined in the experimental design for each specific aim. 
CELL NUMBER MEASUREMENTS USING A HEMOCYTOMETER  
A hemocytometer is used to determine the concentration of cells in a cell 
suspension.  Hemocytometer measurements were used to determine cell numbers on day 
6 of differentiation.  mES cells were directly seeded at varying densities in differentiation 
medium.  For medium containing BME, cells were seeded at densities of 1645, 3290, 
6579, and 13158 cells/cm2 (corresponding to 6250, 12500, 25000, and 50000 cells/well 
respectively).  For medium without BME, cells were seeded at densities of 1645, 2368, 
3290, and 6579 cells/cm2 (corresponding to 6250, 9000, 12500, and 25000 cells/well 
respectively).  On day 6, media was aspirated , the culture was gently washed with pre-
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warmed (37C) phosphate buffered saline (PBS) to remove any unattached cells, and then, 
the culture was incubated with 0.25mL of 1:10 Trypsin/ EDTA (Invitrogen) at 37°C for 1 
min or until all cells were visibly detached.  Two mL of serum containing medium was 
added per well to stop the reaction.  The suspension was vigorously pipetted to sever any 
remaining connections and create a homogenous, single-cell suspension.  Supernatant 
was aspirated, and the cells were resuspended in 250µL PBS.  Of this, 10µL of cell 
suspension was mixed 1:1 with 10µL of 0.4% trypan blue.  Five grids were counted per 
side of the hemocytometer.  Hemocytometer measurements were used to determine cell 
numbers per milliliter.  From this information, cell density was calculated as the total 
number of cells in suspension.  The density measurements were carried out on day 6 of 
culture, as mES endodermal differentiation is known to peak on day 6 [84].  
Measurements for each plating density were carried out for one experimental run, with 
three measurements per run.  
CELL PROLIFERATION USING ALAMAR BLUE ASSAY 
CALIBRATION CURVE 
A calibration is performed before the start of every AB experiment, to be able to 
correlate the fluorescence readings with cell density.  The same culture medium and 
conditions was used for the experiment as for the calibration.  Cells were detached and 
centrifuged, as usual, at 800g for 5 minutes.  Cell pellet was resuspended in 2mL of 
differentiation medium without BME.  Cells at various densities were seeded into the 
wells of a 24-well plate in a small volume of 250µL for optimal distribution and 
attachment.  Densities used were: 1316, 2631, 6579, 13158, 26316, 65789, 131579, 
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263158, 394737 cells/ cm2 (corresponding to 5000, 10000, 25000, 50000, 100000, 
250000, 1000000, and 1500000 cells/ well respectively).  Three wells (called “blank”) 
contained no cells.  Triplicates were used for each seeding density condition.  At 30 
minutes post-seeding, when cells have had time to attach, medium was added to the wells 
to a total volume of 0.45mL per well.  Culture plates were left in the incubator for 2 hours 
for attachment.  Care was taken to keep the room as dark as possible, because AB is 
light-sensitive.  After 2 hours of attachment, 50 µL of Alamar Blue (10%) was added to 
each well, and the plates were kept back in the incubator for another 2 hours, keeping 
them shielded from light.  After 2 hours, 500 µL supernatant from each well of a 24-well 
plate was transferred into two wells (250 µL each) of 96-well plate.  Two readings were 
taken from the same specimen.  Fluorescence readings were taken for the following 
settings: excitation: 530/25 and emission: 580/50 using the Synergy 4 Hybrid Multimode 
Microplate Reader (Biotek Inc.).  While reading the plate, the lid was taken off, because 
condensation on the lid interferes with the reading.  Value for the blank was subtracted 
for all cell densities, and a curve for fluorescence reading against cell density was 
generated. 
PROLIFERATION ASSAY 
 For the proliferation assay, aliquots of the same cells (as the ones used for the 
calibration curve) were seeded at two different densities: 1711 and 3290 cells/cm2 (~ 
6500 cells/ well and 12500 cells/well respectively) in differentiation medium with and 
without 0.1mM BME.  The plates were incubated at 37°C, 5% CO2 and readings were 
taken every 24 hours for 6 days.  Two hours prior to reading, medium was aspirated and 
replaced with new medium containing 10% alamarBlue.  Fluorescence readings were 
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taken using a microplate reader at λexcitation=540 nm and λemission=590 nm and a gain of 35.  
Cells were gently washed with pre-warmed 1X PBS and replaced with fresh media, and 
returned to the incubator until the next time point.  Experiment was performed in 
duplicates for each experimental repeat, with three experimental repeats. 
QUANTITATIVE REAL TIME POLYMERASE CHAIN REACTION (Q-PCR) 
RNA ISOLATION AND PURITY8 
Samples from two wells were pooled per condition per repeat, for three 
experimental repeats.   
HOMOGENIZATION 
Cells were washed once with ice-cold 1X PBS.  Next, cells were lysed directly in a 
culture dish by adding 0.5ml Trizol LS reagent to each well of 12 well plate, scraped 
using a cell scraper, and mixed homogenously by passing the cell lysate several times 
through a pipette.  Lysate was collected in a RNA free eppendorf centrifuge tube, and 
stored on ice.  Each sample was then syringed using a 18 gauge needle, to further ensure 
homogenous lysing. 
PHASE SEPARATION 
The homogenized samples were incubated for 5 min at RT to permit the complete 
dissociation of nucleoprotein complexes, and stored at -80°C until further use.  For RNA 
isolation, the samples were taken out from -800C and thawed at room temperature for 15 
                                                            
8 The microcentrifuge used in this procedure was the uSpeedFuge SFR13K (Savant), and the vortexer was 
VortexGenie 2 (Fisherbrand). 
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minutes and micro-centrifuged at 1000 rpm for 1 minute.  Prior to RNA isolation, the 
area was wiped clean with RNAase free wipes.  0.2 ml of chloroform was added per 1 ml 
of TRIzol LS reagent; sample tubes were capped securely and shook vigorously by hand 
for 15sec and vortexed for 1-3 sec, and incubated at RT for 3-5 minutes.  Samples were 
centrifuged at 12,000x g for 15min at 4°C.  Following centrifugation, the mixture 
separated into a lower red, phenol-chloroform phase, an interphase, and a topmost 
colorless upper aqueous phase.  RNA remains exclusively in the aqueous phase.  The 
volume of the aqueous phase was about 50-70% of the volume of Trizol LS reagent used 
for homogenization.  
RNA PRECIPITATION 
The aqueous phase was transferred to a clean RNA free tube.  RNA was precipitated 
from the aqueous phase by mixing with isopropyl alcohol.  0.5ml of isopropyl alcohol 
was added per 1 ml of TRIzol LS reagent used for the initial homogenization. The tubes 
were manually shaken and incubated at RT for 10 minutes, transferred to RNA-free spin 
filter tubes (Ultraclear Tissue RNA isolation kit - Spin Filters, VWR ) , and centrifuged at 
12000xg for 3 minutes at 4°C.  The filtrate was discarded; 750ul of 75% ethanol was 
added for 1 ml of Trizol, and centrifuged at 7500xg for 2 minutes.  The step was repeated 
again, and the filtrate was discarded.  Samples were spun without adding any solution for 
1 minute at 7500xg, to remove any trapped solution from the filter/RNA.  The filter was 
transferred to a new RNA free tube.  40ul of DEPC water was added and left at RT for 10 
minutes and spun at 10000xg for 3 minutes.  The resultant RNA solution was stored at     
-80°C before proceeding to cDNA synthesis. 
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RNA PURITY 
RNA concentration was measured using the NanoDrop 3300 Fluorospectrometer 
(Thermo Scientific).  2.0 µL of RNA stock was pipetted onto the fluorometer, and the 
measurement was recorded using the ND-3300 software.  The 260/280 ratio, and the 
RNA stock concentration (ng/µL) were noted down from the recorded data.  A260/A280 
ratio was monitored to be between 1.8 – 2.0. 
COMPLEMENTARY-DNA (CDNA) SYNTHESIS 
cDNA synthesis  is the process in which a complementary DNA (cDNA) is 
synthesized from a mature RNA template, using the enzyme Reverse Transcriptase (RT). 
RNA samples were diluted to 50 ng/µL for a total volume of 40 µL.  For cDNA 
synthesis, cDNA cocktail mix was prepared as per table 2 using the High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems), that contains all the necessary 
components (Random Primers, optimized Reverse Transcriptase Buffer or RT Buffer, 
deoxyribonucleotide triphosphate or dNTP and MultiScribe™ MuLV reverse 
transcriptase) for the quantitative conversion of up to 2 µg of total RNA in a single 20 µL 
reaction to single stranded cDNA.  In addition, Nuclease-free water (no diethyl 
pyrocarbonate [DEPC]) is also required for cDNA synthesis.  After adding each reagent 
per table 3.2-1 the mix was tapped, vortexed and spun for 45 seconds.  10 µL of cocktail 
mix was added to 10 µL of sample (at a concentration of ~50 ng/µL).  Samples were 
placed in the Applied Biosystems 9800 Fast Thermal Cycler with 96-Well Aluminum 
Sample Block Module at the following settings: Step 1: 25°C (10 minutes), Step 2: 37°C 
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(120 minutes), Step 3: 95°C (5 minutes), Step 4: 4°C (hold, ∞).  The synthesized cDNA 
is stored at -20°C until further use. 
Table 3.2-1: Cocktail preparation for cDNA synthesis 
 For 1 sample *(N +1) Samples 
10x RT buffer 2.0 ul 2.0*(N +1) ul 
25x dNTP mix 0.8 ul 0.8*(N +1) ul 
10x Random primer 2.0 ul 2.0*(N +1) ul 
Multi-scribe 1.0 ul 1.0*(N +1) ul 
DEPC water 4.2 ul 4.2*(N +1) ul 
Total 10 ul 10*(N +1) ul 
QUANTITATIVE REAL TIME PCR (Q-PCR)  
Real-time PCR (Q-PCR) detects DNA in real-time (i.e.  while the reaction is 
occurring), as opposed to traditional PCR that detects DNA at the end-point (i.e. after the 
reaction has completed).  In addition, real-time PCR enables relative quantitation of gene 
expression allowing quantification of differences in the expression level of a specific 
target (gene) between different samples, normalized to an endogenous gene and relative 
to a particular sample (for example: untreated sample).  The output is expressed as fold-
change or a fold-difference of expression levels.  The endogenous gene used for the 
experiments in this thesis was peptidyl-prolyl isomerase A (cyclophilin A) (PPIA).  
Target genes included Oct-4, Sox-17, and Fox-a2.  All calculations were relative to the 
untreated control on day 0, and normalized to PPIA 
For Q-PCR, cocktail mix was made for each gene per Table 3.2-2.  Q-PCR was 
performed in duplicates for each sample, for three experimental repeats, unless otherwise 
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mentioned.  Mix was made for one or two extra samples to account for pipetting errors.  
After adding each reagent per table 3, the mix was tapped, vortexed and spun for 45 
seconds.  For a list of primers (Applied Biosystems, Inc. [ABI]), refer to table 3.2-3. 
Table 3.2-2: Cocktail preparation for Q-PCR 
 1 sample/ well of 
PCR plate 
 
Duplicates per 
sample 
*(N +1) Samples 
Master Mix 5 µL 10.0 µL 10*(N +1) µL 
Gene/ Primers 0.5 µL 1.0 µL 1.0*(N +1) µL 
DEPC water 3.5 µL 7.0 µL 7.0*(N +1) µL 
Total 9.0 µL 18.0 µL 18*(N +1) µL 
 
Table 3.2-3: List of gene primers 
Gene Name Gene Abbreviation Primers: Applied Biosystems, Inc. 
SRY (sex determining 
region Y)-box 17 
Sox17 ABI Taqman Assay # 
Mm00488363_m1 
Forkhead Box A2 
(also known as 
Hepatocyte nuclear 
factor 3, beta) 
Foxa2/ Hnf3β ABI Taqman Assay # 
Mm00839704_mH 
Octamer-4 
(also known as POU 
class 5 homeobox 1) 
Oct-4/ POU5F1 ABI Taqman Assay # 
Mm03053917_g1 
peptidyl-prolyl 
isomerase A  
(cyclophilin A) 
PPIA 
 
ABI Taqman Assay # 
Mm02342430_g1 
For each sample, tubes were labeled per gene.  18.2µL of cocktail mix specific for 
the gene of interest and 2.1µL of cDNA was added in each of the tubes.  The mixture was 
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tapped, vortexed, and spun for 30-45 seconds, and mixture was pipetted into the well of a 
PCR MicroAMP 48 well plate (10 µL per well, such that there were 2 wells per sample 
per gene).  For each plate, untreated sample (Day 0) was run along with the treated 
samples.  The plate was sealed with the plastic seal, and centrifuged for 1 minute at 
4000rpm at 4°C.  Finally, the plate was loaded into the PCR machine per the following 
settings: (1) 2 minutes, 50°C, (2) 20 seconds, 95°C, (3) 1 second, 95°C, per cycle for 40 
cycles, and (4) 20 seconds, 60°C, per cycle for 40 cycles. 
RELATIVE QUANTITATION OF REAL-TIME PCR DATA USING THE 
COMPARATIVE CT METHOD 
CT stands for cycle threshold.  CT is the cycle number at which the fluorescence 
signal generated within a reaction crosses the threshold line.  The comparative CT (ΔΔCT) 
method was used to generate fold-change in mRNA levels of the treated samples as 
compared to the untreated calibrator control sample (referred to as Day 0) [98]. 
CT values were determined, and this raw amplification data from the Applied Biosystems 
machine was analyzed using the Microsoft Excel 2007, inorder to quantify gene 
expression using the comparative CT method.  The following equations were used [98], 
and the resultant RQ values were plot on Microsoft Excel 2007 for analysis. 
Fold Change or Relative Quantification ሺRQሻ ൌ 2ି∆∆CT     
                                                          ---- Equation (1)                             
2ି∆∆CT ൌ ሾሺCT GOI െ CT ITCሻtreated sampleሿ െ ሾሺCT GOI െ CT ITCሻuntreated sampleሿ  
         ---- Equation (2) 
    where GOI stands for Gene of Interest, and ITC stands for Internal Control (PPIA) 
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IMMUNOFLUORESCENCE 
Immunocytochemistry (IC) is the process of demonstrating a cellular constituent 
in situ by detecting specific antibody-antigen interactions, where the antibody has been 
tagged with a visible label (for example, a fluorescent dye) [99].  For 
immunocytochemistry, samples were stained either in 4-well chamber slides or on 
coverslips.   
FIXATION WITH PARAFORMALDEHYDE 
The purpose of fixation is to preserve samples as close to their biological state as 
possible [99].  Fixation terminates any on-going biological reactions, immobilizes 
antigens, preserves the cellular structure/ sub-structure, and prevents the sample from 
decay.  For all samples used in this study, paraformaldehyde was used as a fixative.  7.4% 
para-formaldehyde (PFA, diluted in PBS) was added to the medium in each well at a 1:1 
ratio (for e.g., 2mL of PFA for every 2 ml of medium per well in a 12-well plate), such 
that the final concentration of PFA was 3.7%.  After 30 minutes, the fixative was pipetted 
off and the cells washed 2 times with 1x PBS without calcium or magnesium (5 
min/wash).  The fixative was quenched with 50mM of glycine for 15 minutes, to quench 
any remaining PFA, and then washed 2 times with 1x PBS (5 min/wash).   
PERMEABILIZATION WITH TRITON X100 
Permeabilization is essential for intracellular and transmembrane markers where 
the epitope is inside the cell (in the nuclear/ cytoplasmic region).  Permeabilization, thus, 
enables the antibody to gain access to epitope of interest [99]. 
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Cells were permeabilized with 0.1% Triton X100 for 20 minutes at room 
temperature, and washed 2 times with 1x PBS (5 min/wash).   
BLOCKING WITH BSA AND SERUM 
Blocking is done to prevent non-specific binding of either the primary or the 
secondary antibody.  Blocking agents like normal sera or bovine serum albumin (BSA), 
block non-specific bindings sites to which antibodies might otherwise bind to.  Normal 
serum comes from non-immunized animals, and it contains a mixture of antibodies.  
These antibodies, thus, will not bind specifically to the target antigen, however, they bind 
to all non-specific binding sites.  Serum used for blocking is from the species in which 
the secondary antibody is raised.  Thus, all non-specific binding sites have antibodies 
from the secondary host stuck to them.  In this way, the secondary antibody does not 
recognize any of these non-specific sites, and binds specifically only to the primary 
antibody.   
Cells were blocked with 1ml of 1% BSA and 1ml of 3% serum for coverslips, and 
500 µL of 1% BSA and 500 µL of 3% serum for chamber slides for 1-2 hours at RT.  For 
Oct4, Foxa2, and Sox17 staining, cells were blocked with chicken serum, as the 
respective secondary antibodies were raised in chicken.  For lectin and cytokeratin 
staining, cells were blocked with fetal bovine serum.  Post blocking, cells were washed 4 
times with 1x PBS (5 min/wash). 
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Table 3.2-4: List of antibodies, dilutions, and blocking agents used for 
Immunocytochemistry. 
Marker Primary 
Antibody 
Secondary Antibody Blocking agent 
Oct-4 
(Self-renewal 
marker) 
Rabbit polyclonal 
anti-Oct-4  
 (ABCAM) 
Alexafluor 488 
(Chicken anti-rabbit) 
(Invitrogen) 
3% Normal Chicken 
Serum 
1% Bovine Serum 
Albumin 
(1:150) (1:500) 
Foxa2 
(Endodermal 
marker) 
Rabbit polyclonal 
anti-FoxA2  
 (Millipore) 
Alexafluor 488 
(Chicken anti-rabbit) 
(Invitrogen) 
3% Normal Chicken 
Serum 
1% Bovine Serum 
Albumin 
(1:100) (1:500) 
Sox17 
(Endodermal 
marker) 
Rabbit polyclonal 
anti-Sox17  
(Millipore) 
Alexafluor 488 
(Chicken anti-rabbit) 
(Invitrogen) 
3% Normal Chicken 
Serum 
1% Bovine Serum 
Albumin 
(1:100) (1:500) 
Pan-
cytokeratin 
(Epithelial cell 
marker) 
Rabbit anti-
cytokeratin (pan)  
(Invitrogen) 
Alexafluor 488 
(Chicken anti-rabbit)  
(Invitrogen) 
3% Fetal Bovine 
Serum  
1% Bovine Serum 
Albumin  
(1:100) (1:500) 
IsolectinB4 
(isoB4) 
(Endothelial 
cell marker) 
Biotinylated 
Griffonia 
(Bandeiraea) 
Simplicifolia 
Lectin I (Isolectin 
B4) (Vector 
Laboratories) 
Texas Red Avidin D  
(Vector Laboratories) 
3% Fetal Bovine 
Serum  
1% Bovine Serum 
Albumin 
(15 µg) (15 µg) 
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PRIMARY ANTIBODY INCUBATION 
Cells were incubated with primary Abs, diluted in dilution medium (3% serum, 1x 
PBS/Ca/Mg) kept overnight (12-16 hours) at 4°C.  The dilutions of primary antibodies 
used were as follows: Oct4, 1:150, Foxa2, 1:100; Sox 17, 1:100; Griffonia 
simplicifolia lectin I-isolectinB49 (isoB4) (15ug), and pan-cytokeratin (1:100).  For the 
negative control, primary antibody was omitted to assess nonspecific staining.  After 
overnight incubation, samples were washed 3 times with 1x PBS.  For a concise list of 
antibodies, antibody dilutions, and blocking agents used for the work in this thesis, refer 
to Table 3.2-4. 
SECONDARY ANTIBODY INCUBATION 
Samples were stained with fluorescently tagged secondary antibodies at a dilution 
of 1:500 or Texas Red avidin (15ug) in dilution medium (3% serum, 1x PBS/Ca/Mg) for 
1 hour at room temperature and washed three times with 1x PBS.  Table 3.2-4 gives 
details of the specific antibodies used for each gene of interest.  
NUCLEAR COUNTER STAIN DAPI INCUBATION 
Post secondary antibody incubation and washing, samples were stained with 4’, 6-
diamidino-2-phenylindole, dilactate [DAPI] (1:1000) for 30 minutes.  Cells were washed 
with 1X PBS 5 times.  
 
                                                            
9 Griffonia simplicifolia lectin (isolectin B4) was used as a marker for endothelial cells because it has been shown to 
bind specifically to endothelial cells in mouse tissues [120]. 
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FLUORESCENCE IMAGING 
Samples were mounted for microscopy with Vectashield mounting medium.  
Microscope cover glass edges were sealed with nail polish and stored in the dark at 4°C 
prior to imaging.  All fluorescent images were acquired using a Leica DMRX inverted 
microscope equipped with a DFC 300 FX camera (Leica, Wetzlar, Germany) with Leica 
imaging software, and processed using Adobe Photoshop CS2 (Adobe Systems, San Jose, 
CA). 
MORPHOLOGY 
Representative phase-contrast images from all samples were acquired using a 
Nikon ELWD 0.3 (Nikon, Japan) inverted microscope equipped with a Nikon 80-200/4 
camera lens (Nikon, Japan) with Leica imaging software, and processed using Adobe 
Photoshop CS2 (Adobe Systems, San Jose, CA).  
STATISTICAL ANALYSIS 
The number of repeats per experiment, and the number of replicates per repeat for all the 
experiments in this thesis is indicated below: 
o Hemocytometer measurements (1 experimental repeat, 3 replicates/repeat) 
o alamarBlue Assay (3 experimental repeats, 2 replicates/repeat) 
o Q-PCR (3 experimental repeats, 1 replicate/repeat) 
 1 replicate = 1 data point = sample pooled from 2 wells 
 Duplicate wells/ data point to account for technical repeatability 
during PCR 
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o Immunostaining (3 experimental repeats, 1 replicate/repeat) 
Where possible, data was presented as mean ± standard deviation (mean ± SD).  One way 
ANOVA (Microsoft Office Excel, 2007) was used to determine significant differences, 
with p<0.05 regarded as statistically significant. Bars indicate standard deviation. 
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CHAPTER 4: RESULTS 
4.1 OPTIMIZATION OF SEEDING DENSITY FOR ES-D3 DIFFERENTIATION 
The aim was to find an optimum seeding density for two different media, with or 
without BME, such that the medium would allow for expansion in a 12 well plate for 8 
days without passaging.  ES-D3 cells were seeded at varying cell densities in base 
medium supplemented with 10% FBS, and further augmented with or without BME, and 
cultured for a period of 6 days.  On day 6, cells in each well were detached and counted 
using a hemocytometer to calculate the number of viable cells. 
CELL COUNTING USING HEMOCYTOMETER 
For medium containing BME, cells were seeded at densities of 1645, 3290, 6579, 
and 13158 cells/cm2 (corresponding to 6250, 12500, 25000, and 50000 cells/well 
respectively).  For medium without BME, cells were seeded at densities of 1645, 2368, 
3290, and 6579 cells/cm2 (corresponding to 6250, 9000, 12500, and 25000 cells/well 
respectively).  As seen in Figure 4.1-1 below, number of viable cells were significantly 
higher in medium containing BME for all seeding densities, indicating that BME 
enhances cell survival.  However, in order figure out the optimum seeding density, the 
data from cell counting and phase contrast microscopy was analyzed further, as seen in 
Figures 4.1-2 and 4.1-3. 
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Figure 4.1-1: Viable Cell Number Determination using a Hemocytometer.  ES-D3 cells were 
seeded at varying seeding densities and were cultured in two different media (with or 
without BME) in standard-sized areas (3.8 cm2, corresponding to one well of a 12-well plate) 
for 6 days.  Viable cells were counted using a hemocytometer by inverted, phase-contrast 
microscopy.  X-axis represents the number of cells seeded initially.  Y-axis represents the 
number of viable cells (x 106) after 6 days in culture in differentiation medium.  Inset: An 
enlarged view of the lower graph displaying number of viable cells in medium without BME 
(blue).  Data is represented as mean ± SD of one independent experiment, and 
representative triplicate measurements.  When the SD is not displayed, it is smaller than the 
size of the symbol.  Number of viable cells were significantly higher in medium containing 
BME (red), as compared to medium without BME (blue) (**P < 0.0001, *P < 0.0005).   
MORPHOLOGY AND FOLD INCREASE 
Using the data from cell counting, fold increase was calculated as the ratio of 
number of cells on day 6 and number of cells seeded initially.  Fold increase data and 
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phase-contrast morphology were analyzed to assess the effect of initial cell seeding 
density on cellular proliferation and differentiation of ES-D3 cells.  An underlying 
assumption for fold increase calculations was that cell growth is symmetric, which may 
not be entirely true as the cells were cultured in differentiation medium.  Figures 4.1-2 
and 4.1-3 display graphs for fold increase in cell number in both media. 
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Figure 4.1-2: Fold Increase in cell number for medium containing BME.  Data is 
represented as mean ± SD of one independent experiment, and representative triplicate 
measurements.  Fold increase was highest for cells plated at a density of 3290 cells/cm2 (~ 
12500 cells/ well) (*P < 0.05 compared to all other plating densities).  As seen in the phase 
contrast photomicrographs, at the lowest plating density, cells were sparsely spread, and 
cell-cell contact was minimal..  In comparison, at higher plating densities, cells were 
confluent after 6 days, exhibiting higher cell-cell interaction.  Cells were over-confluent at a 
plating density of 13158 cells/cm2 (~50000 cells/well), and fold increase in cell number was 
relatively low.  Scale: 100 µm.  
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Figure 4.1-3: Fold increase in cell number in medium without BME.  Data is represented as 
mean ± SD of one independent experiment, and representative triplicate measurements.  
Cell numbers decreased initially for a plating density of 2368 cells/cm2 (~9000 cells/well) and 
increased linearly thereafter as the plating density increased.  Fold increase was highest for 
cells plated at a density of 6579 cells/cm2 (~25000 cells/well) (*P < 0.05 compared to all other 
plating densities).  As seen in the phase contrast photomicrographs, at the lowest plating 
density, cell-cell contact was minimal.  Cells were sparsely spread, and there was ample 
room for growth.  In comparison, at higher plating densities, cells were confluent after 6 
days, exhibiting higher cell-cell interaction.  Even at the highest plating density, there was 
some room for growth.  This is also indicative from the linear increase in cell number.  
Scale: 100 µm. 
Colonies of differentiated cells were observed in both media at all seeding densities, 
indicating that both media promote differentiation.  Differentiated cells exhibited 
cobblestone like epithelial cell morphology, satisfying design criterion 3.  Number of 
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viable cells were significantly higher in medium containing BME.  In addition, culture 
displayed morphology that consisted of both undifferentiated (island like clusters) and 
differentiated (cobblestone like single cells) morphology, indicating both proliferation 
and differentiation.  In medium containing BME, cell numbers were higher, with a 
maximum of 99-fold in comparison to the initial plating density.  On the other hand, cells 
in media without BME occupied less area, exhibited sparse colonies of differentiating 
cells (1-2 per well), and exhibited very low cell numbers after 6 days in culture (1-3 fold).  
Less proliferation was observed in medium without BME as shown by few colonies.  
This might be an indication of less cell survival, due to the absence of anti-oxidant BME.  
In contrast to cells in medium containing BME, cells in medium without BME mostly 
displayed differentiated morphology.  In summary, fewer cells survived in differentiating 
medium without BME in comparison to medium containing BME.  
Table 4.1-1: Range of seeding densities for two different media, with and without BME. 
 Low Cell 
Seeding Density 
Moderate Cell 
Seeding Density 
High Cell 
Seeding Density 
Differentiating 
Medium with BME 
1645 cells/cm2 3290 cells/cm2 6579 – 13158 
cells/cm2 
Differentiating 
Medium without 
BME 
1645 cells/cm2 3290 cells/cm2 6579 cells/cm2 
Table 4.1-1 gives the range of cell numbers for low, moderate, and high cell seeding 
densities.  For both media, at the lowest plating densities, cell-cell contact was minimal, 
there was ample space for growth, but differentiating colonies were relatively fewer as 
compared to higher plating densities.  At moderate cell plating densities, cell-cell contact 
was moderate (more than that at low plating densities, but less than those at high plating 
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densities), cells were moderately confluent, exhibited differentiated morphology, as well 
as high cell numbers.  At high plating densities, cells were over-confluent, there were 
more floating cells, cell growth seemed arrested, and fold increase in cell number 
dropped.  In summary, at low plating densities (less cell-cell interaction, no contact 
inhibition), fold increase in cell number was high.  At moderate plating densities 
(moderate cell-cell interaction, minimal contact inhibition), fold increase in cell number 
was highest.  At high plating densities (very high cell-cell interaction, maximum contact 
inhibition), fold increase in cell number dropped.  Our results are in agreement with a 
recent study that shows that a moderate cell seeding density (in our case, 3290 cells/cm2) 
promotes rapid proliferation, whereas higher cellularity (in our case, 6579 - 13158 
cells/cm2) induces contact inhibition, which in turn might suppress cell proliferation 
[100].   
 Lee et al. has shown that managing cell-cell interaction by maintaining colony sizes 
controls self-renewal and differentiation (into specific lineages) of embryonic stem cells 
[101].  Similarly, Kim et al. has shown that initial cell seeding of bone marrow stromal 
cells controls paracrine cell-cell interaction, which in turn controls proliferation and 
differentiation of these cells [100].  Murine embryonic stem cells also require an optimal 
cell seeding density with appropriate cell-cell interaction and minimal contact inhibition 
during the exponential phase of a growth curve for appropriate proliferation and 
differentiation.   
Based on this and our data, we chose the optimum cell seeding densities for both 
differentiating media, such that they would promote cell expansion for 8 days without 
passaging, and yield a relatively high fold increase in cell number (in meeting the design 
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criteria outlined under Table 2.4-1 under Design Component).  Our data indicates that 
moderate seeding density promotes differentiation of mES cells into endoderm cells (as 
assessed by the epithelial morphology of the differentiated colonies).  For media 
containing BME, cells survived best at 3290 cells/cm2 (moderate seeding density) for 6 
days.  However, since the ultimate application was to differentiate these cells for 8 days, 
a cell plating density of 2632 cells/cm2 (~ 10,000 cells/well) was chosen such that it 
would allow for expansion (both proliferation and differentiation) without passaging.  For 
media without BME, cell survival was not sufficient at a low plating density, but 
improved at moderate plating density, with the best survival at high plating density.  
Once again, since the end application was to differentiate these cells for 8 days, a seeding 
density of 5263 cells/cm2 (~ 20000 cells/well), such that it was slightly less than the high 
end plating density, was chosen. 
ALAMAR BLUE PROLIFERATION ASSAY 
Next, alamarBlue proliferation assay was performed at two different densities, one at 
the low end of 6250cells/ well and another at 12500 cells/well in order to (1) determine 
the proliferation profile of ES-D3 cells in differentiation medium, and (2) to back up the 
results from cell counting.  Continued cell growth maintains a reduced environment while 
inhibition of growth maintains an oxidized environment.  Resazurin, a non-fluorescent 
indicator dye in alamarBlue, is converted to bright red–fluorescent resorufin via the 
reduction reactions of metabolically active cells.  When cells are metabolically inactive, 
the dye is blue in color, but upon metabolic activity, the dye takes a bright red color.  
Fluorescence intensity is used to measure metabolic activity of the cultured cells.  The 
amount of fluorescence produced is proportional to the number of living cells.   
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Next, proliferation assay was performed for a period of 6 days, at two different 
plating densities, 1645 cells/cm2 (~6250 cells/ well) and 3290 cells/cm2 (~12500 cells/ 
well), as seen in Figures 4.1-5 and 4.1-6 respectively. 
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Figure 4.1-5:  ES-D3 Proliferation curve over 6 days at an initial plating density of 1645 
cells/ cm2 (~6250 cells/well) in medium with and without BME.  The x-axis represents time 
in culture (days) and the y-axis represents normalized cell density (cells/well).  For medium 
containing BME (red), cell density increases over time.  In contrast, for medium without 
BME (blue), cell density stays more or less constant.  Cell proliferation is higher in medium 
containing BME (*P < 0.05, **P < 0.01) as compared to the respective data points in 
medium without BME).  Data is represented as mean ± SD of three independent 
experiments, with duplicate measurements per experiment.   
At an initial plating density of 1645 cells/cm2, cell density increases over time, 
with a maximum of about 22368 cells/cm2 (~85000 cells/well) on day 6 in medium 
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containing BME.  At this moderate initial plating density, cell density increases over 
time, with a maximum of about 78947 cells/cm2 (~300000 cells/well) on day 6 in 
medium containing BME.  In contrast, cell density increases minimally in medium 
without BME, with a maximum of 13158 cells/cm2 (~50000 cells/well) on day 6.   
For both plating densities, proliferation profile in medium containing BME 
exhibits a lag phase, an exponential phase, and a stationary phase (plateau).  In contrast, 
proliferation profile remains nearly constant in medium without BME, indicating 
minimal proliferation.  Figure 4.1-7 below compares the proliferation profiles from 
figures 4.1-5 and 4.1-6, and displays the calculated fold increase in cell number.  
Proliferation curves in both media are higher at a moderate plating density of 3290 
cells/cm2, as compared to a low plating density of 1645 cells/cm2.   
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Figure 4.1-7: Comparison of the proliferation profile and fold increase in cell number for 
two different plating densities.  (A1, A2)  Cell density after 6 days in culture is significantly 
higher at a plating density of 12500 cells/well in medium containing BME (*P < 0.05, **P < 
0.01) as compared to the corresponding data points in medium without BME. Data is 
represented as mean ± SD of three independent experiments, with duplicate measurements 
per experiment.  (B1, B2)  Tables display fold increase in cell number over a period of 6 
days.  At a plating density of 6250 cells/ well, fold increase in cell number is 10-fold higher 
(12 versus 2) in medium containing BME.  Similarly, at a plating density of 12500 cells/well, 
fold increase in cell number is 17-fold higher (22 versus 5) in medium containing BME.  
Fold increase in cell number in medium containing BME is higher than medium without 
BME, with the highest fold increase at a plating density of 12,500 cells/well (3290 cells/cm2) 
in medium containing BME.    
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Results from alamarBlue assay, thus, in coherence with results from direct cell 
counting and morphological evidence, indicate a potential role of BME in cell survival.  
Taken together, medium containing BME supports cell growth.  Cell density profile 
shows an increasing profile, and fold increase in cell number is higher in medium 
containing BME.   
Although cell proliferation in both media show similar trends using both direct 
cell counting and alamarBlue, an important finding of these experiments is that fold 
increase in cell number due to alamarBlue is not in coherence with fold increase in cell 
number from direct cell counting, in spite of similar culture conditions (See Table 4.1-2).  
Cells were plated at an initial density of 3290 cells/cm2 in two media, with and without 
BME.  
Table 4.1-2: Comparison of fold increase in cell number using two different methods: (1) 
Direct Cell Counting, and (2) Alamar Blue Assay.   
 Direct Cell Counting alamarBlue Assay 
Medium containing BME  99.2 22.05 
Medium without BME  1.6 4.74 
This discrepancy owes to the fact that alamarBlue assay is a direct measure of 
cellular metabolic activity, and not cell numbers.  This indicates that alamarBlue assay 
might not be a reliable method to measure stem cell growth. 
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4.2 OPTIMIZATION OF DIFFERENTIATION MEDIUM FOR ES-D3 
DIFFERENTIATION INTO ENDODERM CELLS 
Differentiation medium was optimized for base medium supplemented with and 
without BME.  mRNA expression of two genes, Oct4 (marker for pluripotency) and 
Foxa2 (marker for endoderm cells), was evaluated using Q-PCR.   
MEDIUM SUPPLEMENTED WITHOUT BME 
ES-D3 cells were differentiated for 6 days under the following conditions: 
DMEM without BME or Activin-A supplemented with either 10% FBS, 5% FBS, 2% 
FBS, and A549 conditioned medium mixed with DMEM 10% FBS (50:50 v/v).  Figure 
4.2-1 displays Q-PCR results for relative quantification of mRNA levels of Oct-4 and 
Foxa2.  After 6 days, cells survived only in medium containing 10% FBS.  Foxa2 
expression increases, whereas Oct-4 expression declines in medium containing 10% FBS 
as compared to the control (undifferentiated cells) (*P < 0.01).  This indicates that mES 
cells start losing their pluripotency, but acquire a more differentiated state upon LIF 
withdrawal.  For medium containing 5% FBS, 2% FBS, and A549 conditioned medium 
(with a final concentration of 5% serum), most cells died after 6 days in culture, as 
indicated by the picture in the graph.  Decreasing concentration of serum in medium 
without BME did not support cell survival, indicating a role of serum/serum factors in 
cell survival.  For medium without BME, DMEM 10% FBS was chosen as the optimum 
medium. 
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Figure 4.2-1: Q-PCR results for ES-D3 differentiation medium optimization, for base 
medium supplemented without BME.  Data is represented as mean ± SD of three 
independent experiments, with one measurement (= sample pooled from two wells) per 
experiment, and duplicate readings for Q-PCR per measurement.  Green represents Oct-4, 
and red represents endoderm marker Foxa2.  Y-axis represents relative quantification of 
gene expression, as calculated by the delta-delta Ct method.  AA refers to Activin-A.  
Control refers to untreated cells on day 0 (undifferentiated cells).  After 6 days, cells 
survived only in medium containing 10% FBS.  Foxa2 expression is significantly higher (~5 
fold higher than the control), whereas Oct-4 expression is significantly less (*P < 0.01).  For 
medium containing 5% FBS, 2% FBS, and A549 conditioned medium (with a final 
concentration of 5% serum), most cells died after 6 days in culture, as indicated by the 
picture in the graph. 
MEDIUM SUPPLEMENTED WITH BME 
ES-D3 cells were differentiated for 6 days in medium containing BME, which 
was further supplemented with varying serum concentrations, either 10% FBS, 5% FBS, 
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or 2% FBS.  Each of these media were further supplemented with 20ng/ml of Activin-A.  
Medium without Activin-A was considered as a control for each medium.  Cells were 
also differentiated in A549 conditioned medium mixed with DMEM 10% FBS (50:50 
v/v).  Figure 4.2-2 displays Q-PCR results for Oct-4 and Foxa2. 
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Figure 4.2-2:  Q-PCR results for ES-D3 differentiation medium optimization, for base 
medium supplemented with BME.  Data is represented as mean ± SD of three independent 
experiments, with one measurement (= sample pooled from two wells) per experiment, and 
duplicate readings for Q-PCR per measurement.  Green represents Oct-4, and red 
represents endoderm marker Foxa2.  Y-axis represents relative quantification of gene 
expression, as calculated by the delta-delta Ct method.  AA refers to Activin-A.  Control 
refers to cells on day 0 (undifferentiated cells).  After 6 days, cells did not survive in medium 
supplemented with 2% serum (results not shown).  Foxa2 expression was nearly the same 
for media supplemented with Activin-A, and A549 conditioned medium.  Highest Foxa2 
expression was seen in DMEM supplemented with 5% FBS, but without Activin-A.  * 
indicates a statistical difference compared to the control, while ** indicates a statistical 
difference compared to DMEM 10% FBS without Activin-A (P < 0.05). 
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As seen in Figure 4.2-2, for media supplemented with Activin-A, Foxa2 
expression was only 2 or 3 fold higher in comparison to the control.  For DMEM 10% 
FBS, no Activin-A control showed higher Foxa2 expression than medium with Activin-A 
(2.5 fold higher).  Similarly, for DMEM 5% FBS, no Activin-A control showed higher 
Foxa2 expression than medium with Activin-A (7.5 fold higher).  This supports the 
premise that under certain circumstances (such as in the presence of serum) Activin-A 
inhibits endodermal differentiation of ES-D3 cells [57].  Endodermal expression as 
assessed by Foxa2 expression, was highest (9.5 fold higher than control) in DMEM 5% 
FBS w/o Activin-A.  Oct-4 expression was also significantly less in DMEM 5% FBS w/o 
Activin-A, indicating that pluripotency is decreasing, and differentiation is increasing.  
FoxA2 Expression in A549 conditioned medium: DMEM 10% FBS 50:50 (v/v) was 
similar to that of DMEM 5% FBS with Activin-A, and DMEM 10% FBS with Activin-A, 
indicating that there is Activin-A in serum or conditioned medium.   
In summary, for base medium supplemented with BME, DMEM 5% FBS showed 
highest Foxa2 expression (P < 0.05 in comparison to control), and was chosen as the 
optimum media for ES-D3 differentiation into endodermal cells. 
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4.3 EFFECTS OF VARYING OXYGEN TENSION ON ENDODERMAL 
DIFFERENTIATION 
The following optimized parameters were used for experiments in specific aim 3: 
1. Seeding density:  
a. 2632 cells/cm2 (~10,000 cells/well) for medium containing BME 
b. 5263 cells/cm2 (~20,000 cells/well) for medium without BME 
2. Differentiation medium 
a. DMEM 5% FBS for medium containing BME 
b. DMEM 10% FBS for medium without BME. 
Based on this, ES-D3 cells were differentiated under 1% O2, 3% O2, 8% O2, and 
21% O2, as shown in Figure 2.4-5.  Gene expression was assessed at the mRNA and 
protein level using Q-PCR and immunofluorescence respectively on days 2, 4, 6, and 8.  
Undifferentiated cells at day 0 served as a control.  mRNA expression of three genes, 
Oct4 (marker for pluripotency), Foxa2 and Sox17 (markers for endoderm cells), was 
evaluated using Q-PCR.  Protein expression was also evaluated for the same markers.  In 
addition, endothelial cell marker isolectin B4, and epithelial cell marker cytokeratin were 
also assessed using immunofluorescence.  In addition, morphology was also monitored, 
and phase contrast microscopy was performed for all experiments. 
ES-D3 DIFFERENTIATION UNDER 3% OXYGEN TENSION 
Before performing any experiments under reduced oxygen tension, it was 
essential to test the effect of only BME on ES-D3 differentiation.  Since ES-D3 cells 
were routinely maintained in DMEM 10% FBS, 0.1mM BME, and 1000 U/ml LIF, we 
decided to assess the effect of BME under base media conditions.  LIF was withdrawn, 
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and cells were differentiated in DMEM 10% FBS supplemented with and without 0.1mM 
BME under 3% O2.  Cells differentiated in less than 21% O2 were used as a control.  
From this study, it was found that for both media, Sox17 and Foxa2 expression was 
higher under 21% O2 as compared to 3% O2.  Under 21% O2, medium without BME 
showed higher Foxa2 and Sox17 expression.   
ES-D3 DIFFERENTIATION UNDER 1% AND 8% OXYGEN TENSION 
For experiments under 1% and 8% O2, cells were differentiated under two 
different conditions: (1) DMEM 10% FBS – with and without BME, and (2) DMEM 5% 
FBS – with and without BME.  Under 1% O2, cells died in all media on day 6 indicating 
that for our culture conditions, 1% O2 does not promote cell survival, even in medium 
containing BME.  Under 8% O2 and 21% O2, cells died in DMEM 5% FBS without 
BME.  Under 8% O2, ES-D3 cells followed the same trend as that seen under 3% O2, in 
that Sox17 and Foxa2 gene expression was suppressed under reduced oxygen tension. 
Cumulative results from this specific aim are shown in Figures 4.3-1 and 4.3-2. 
Q-PCR 
Figure 4.3-1 shows cumulative Q-PCR results for fold increase in Sox17 
expression.  For DMEM 10% FBS with BME, Sox17 expression shows a nearly similar 
profile under 3%, 8% as well as 21% O2.  For DMEM 10% FBS without BME, fold 
increase in Sox17 expression was highest under 21% O2 on day 8 (35 fold).  For DMEM 
5% FBS with BME, fold increase in Sox17 expression was highest under 21% O2 on day 
8 (45 fold).  Taken together, DMEM 5% FBS with BME promotes induces maximum 
Sox17 expression under normoxic conditions.   
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Figure 4.3-2 shows cumulative Q-PCR results for fold increase in Foxa2 
expression.  Foxa2 expression shows a similar profile as Sox17 in all media under all 
oxygen levels.  For DMEM 10% FBS with BME, Foxa2 expression shows a nearly 
similar profile under 3%, 8% as well as 21% O2.  For DMEM 10% FBS without BME, 
fold increase in Foxa2 expression was highest under 21% O2 on day 8 (10 fold).  For 
DMEM 5% FBS with BME, fold increase in Sox17 expression was highest under 21% 
O2 on day 8 (20 fold).  Taken together, DMEM 5% FBS with BME induces maximum 
Foxa2 expression under normoxic conditions (P < 0.05), as compared to other 
experimental groups (1%, 3%, and 8% O2).   
Figure 4.3-3 shows Q-PCR results for fold increase, in Oct4, Foxa2, and Sox17 
expression under the optimum conditions of DMEM 5% FBS with BME, and 21% O2. 
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Figure 4.3-1: Q-PCR results for Fold Increase in Sox17 expression in different media for 
different oxygen levels.  21% O2 (green), 8% O2 (red), and 3% O2 (blue).  Experiments were 
run for 8 days; mRNA levels were evaluated at the following time points.  (A) Sox17 
expression in DMEM 10% FBS with BME for different oxygen levels.  (B) Sox17 expression 
in DMEM 10% FBS without BME for different oxygen levels.  (C) Sox17 expression in 
DMEM 5% FBS with BME for different oxygen levels.  Data is represented as mean ± SD of 
three independent experiments, with one measurement (= sample pooled from two wells) 
per experiment, and duplicate readings for Q-PCR per measurement.  * P < 0.05, ** P < 
0.01, indicates statistical difference compared to control, whereas ††P <0.01 indicates 
statistical difference compared to respective data points in other groups (3% O2, 8% O2).  
 
P a g e  | 90 
 
0
5
10
15
20
25
30
Day 0 Control Day 2 Day 4 Day 6 Day 8
Fo
ld
 In
cr
ea
se
 in
 G
en
e 
Ex
pr
es
si
on
FoxA2 Expression: DMEM 10% with BME
3% O2
8% O2
21% O2
A
0
5
10
15
20
25
30
Day 0 Control Day 2 Day 4 Day 6 Day 8
Fo
ld
 In
cr
ea
se
 in
 G
en
e 
Ex
pr
es
si
on
FoxA2 Expression: DMEM 10% without BME
3% O2
8% O2
21% O2
B
* †* †
0
5
10
15
20
25
30
Day 0 Control Day 2 Day 4 Day 6 Day 8
Fo
ld
 In
cr
ea
se
 in
 G
en
e 
Ex
pr
es
si
on
FoxA2 Expression: DMEM 5% with BME
8% O2
21% O2
C
* †
* †
 
Figure 4.3-2: Q-PCR results for Fold Increase in Foxa2 expression in different media for 
different oxygen levels.  21% O2 (green), 8% O2 (red), and 3% O2 (blue).  Experiments were 
run for 8 days; mRNA levels were evaluated at the following time points: d0, d2, d4, d6, and 
d8.  (A) Foxa2 expression in DMEM 10% FBS with BME for different oxygen levels.  (B) 
Foxa2 expression in DMEM 10% FBS without BME for different oxygen levels. (C) Foxa2 
expression in DMEM 5% FBS with BME for different oxygen levels.  Data is represented as 
mean ± SD of three independent experiments, with one measurement (= sample pooled from 
two wells) per experiment, and duplicate readings for Q-PCR per measurement.  * P < 0.05 
indicates statistical difference compared to control, whereas †P <0.01 indicates statistical 
difference compared to respective data points in other groups (3% O2, 8% O2). 
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Figure 4.3-3: Q-PCR results for Fold Increase in Oct4, Foxa2, and Sox17 expression in 
DMEM 5% FBS with BME under normoxic conditions (21% O2).  Experiment was run for 
8 days; and mRNA levels were evaluated at the following time points: d0, d2, d4, d6, and d8.  
Inset: Enlarged version of fold increase in Oct4 expression. Oct4 (green), Foxa2 (red), and 
Sox17 (blue).  Data is represented as mean ± SD of three independent experiments, with one 
measurement (= sample pooled from two wells) per experiment, and duplicate readings for 
Q-PCR per measurement.  * P < 0.05, **P <  0.01 indicates statistical difference compared 
to the control. 
 Figure 4.3-3 indicates that as time increases, mRNA expression of endodermal 
markers Sox17 and Foxa2 increases significantly, whereas expression of pluripotency 
marker Oct4 decreases significantly.  Thus, for differentiating medium DMEM 5% FBS 
with BME, observations indicate that undifferentiated cells decrease significantly, and 
differentiated cells increase significantly over time.  DMEM 5% FBS with BME under 
ambient air (21% O2) was chosen as the optimum differentiating medium.  
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 Immunofluorescence images confirmed presence of epithelial-like (cyto-keratin) 
and endothelial-like (isolectin B4) cells, in addition to endodermal markers (Foxa2, and 
Sox17) in cells differentiated in the optimum medium, DMEM 5% FBS with BME.  
Undifferentiated cells distinctly displayed pluripotency marker Oct-4. 
MORPHOLOGY 
In addition to Q-PCR and immunofluorescence, cellular morphology was 
monitored at each time point (days 0, 2, 4, 6, and 8), and photomicrographs were 
acquired using conventional phase-contrast microscopy.  Figure 4.3-6 displays 
representative images for endodermal differentiation (as observed by epithelial-like 
morphology) for all media.  Undifferentiated cells on day 0 display island-like aggregates 
in medium containing LIF.  Upon LIF withdrawal, cells start spreading from an aggregate 
(day 2) and start growing out from an undifferentiated core (day 4).  Single cells at the 
periphery start showing differentiated morphology around day 6, and by day 7/8 display 
distinct cobblestone like morphology representative of epithelial-like cells.   
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CHAPTER 5: DISCUSSION AND FUTURE WORK 
Previous studies have shown that endoderm induction in vitro is a complex and dynamic 
procedure that requires recapitulating developmental pathways, and use of complex serum-free 
medium formulation [27,45,47,92,102,103].  A major goal of the field is, therefore, to create a 
simple, permissive, ES cell culture system that could encourage fundamental research without 
the need for complex designed systems [57].    
ES cell differentiation, upon withdrawal of the self-renewal mediator LIF, is 
accompanied by apoptosis [104].  Apoptosis is a physiological, multi-step genetic cell death 
program that occurs during the early stages of embryogenesis.  This natural cell death in ES cells 
is imperative to the formation of cavities in the blastocyst stage of embryonic development.  
Duval et al. have shown, using the mouse ES model (S1 mES cell line, derived from mouse 129 
strain) that about 30% of mES-derived cells die by apoptosis, 3 days upon LIF withdrawal (d3) 
[81].  The remaining cells that express BCL2 and BCLx/L proteins become resistant to 
apoptosis, and further continue differentiation into specific lineages [81].  Differentiation and 
apoptosis are, thus, linked and our culture confirmed this finding, as demonstrated by a high 
number of floating or unattached cells, especially after day 3 in culture.  Previous studies have 
shown that regulation of such apoptotic pathways is critical for proper embryonic development.  
Strategies to control apoptosis while unaffecting the differentiation process are, therefore, of 
great importance for stem cell research. 
 Many studies have emphasized the importance of mimicking the embryonic 
microenvironment in order to maximize the differentiation potential of ES cells [70].  A major 
component of embryonic microenvironment is low oxygen levels (also termed as physiologic 
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oxygen levels) [79], and these microenvironments create niches that regulate cellular 
differentiation [61].  Recently, Gebb and colleagues demonstrated that fetal lung explants show 
increased terminal branching and cellular proliferation at 3% O2 in culture [70].  Lung branching 
provides a template for lung angiogenesis, and low tissue oxygen levels in the developing lung 
enhance the branching of pulmonary vasculature as well.  Due to the indispensable role of 
oxygen in regulating lung embryonic development, we hypothesized that physiologic oxygen 
levels would enhance endodermal differentiation.   
While low oxygen levels may potentially enhance differentiation of ES cells, they are 
accompanied by an activation of apoptotic pathways that, along with LIF withdrawal, lead to 
enhanced cell death.  The severity of hypoxia (<5% O2) determines whether cells become 
apoptotic or adapt to hypoxia and survive.  Low oxygen levels also give rise to increased reactive 
oxygen species, which threaten cell survival by oxidative stress [105].  Earlier, we discussed the 
role of LIF withdrawal on cell differentiation and apoptosis.  Thus, under reduced oxygen 
tension, both LIF withdrawal and increased ROS, contribute to enhanced cell death.  To address 
this problem of minimal cell survival under reduced oxygen levels, we explored use of an anti-
oxidant, beta-mercaptoethanol (BME), which is known to promote cell survival by scavenging 
reactive oxygen species [79].  We hypothesized that both reduced oxygen tension and anti-
oxidants, would enhance endodermal differentiation of ES-D3 cells.  In addition to oxygen levels 
and anti-oxidants, a variety of parameters including differentiating medium (growth factors, 
morphogens, and cytokines), serum concentration, as well as cell seeding density influence 
differentiation of ES cells.  Our overall hypothesis is that an optimum microenvironment 
(paracrine cell-to-cell distance determined by initial cell seeding density, serum concentration, 
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differentiating medium, as well as optimal physiologic oxygen levels) could facilitate 
endodermal signals among cultured mES cells population. 
A major part of the optimization process before running experiments under reduced 
oxygen tension was, to optimize the seeding density and differentiation medium for ES-D3 
differentiation. 
Studies have shown that cell-seeding density, which can alter intercellular paracrine cell-
to-cell communication distance, may be a critical parameter in controlling subsequent cellular 
proliferation, differentiation, and apoptosis [100].  As shown in recent literature, cell 
proliferation is strongly regulated by (1) surface area to allow attachment, (2) cellular co-
operativity10, and (3) contact-inhibition11 between adjacent cells [100,106-108].   
 The alamarBlue proliferation curves, and cell counts using a conventional 
hemocytometer, indicated that a moderate seeding density (2632 cells/cm2 for medium 
containing BME, and 5263 cells/cm2 for medium without BME) was optimum for differentiation 
of ES-D3 cells.  The difference in optimum cell seeding in medium with and without BME can 
be attributed to the ROS scavenging property of BME. 
alamarBlue growth curves revealed that, in the absence of BME, growth curve remained 
more or less the same.  This might be an indication of a balance between proliferation, 
differentiation, and apoptosis.  In contrast, in the presence of BME, cell growth curve exhibited a 
typical profile of growth curves of live organisms –showing a lag phase, an exponential 
 
10 Higher cell‐cell contact also gives rise to cellular co‐operativity.  Co‐operativity means that different parts of the 
system are tied together, and thus co‐operativity forces cells to undergo transition together.   
 
11 When cells touch other cells in a culture plate, they stop growing and moving.  This is defined as contact 
inhibition of cell growth and movement.   
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logarithmic phase, a plateau stationary phase, and a declining death phase as seen in Figure 4.3-1 
below. 
 
Figure 5-4.3-1: Typical Bacterial Growth curve, representing the various phases of cellular growth.  
Curve displays the lag phase, log or exponential phase, stationary phase, and death phase of 
growth.  Figure adapted from [109]. 
In medium containing BME, for the first two days, almost no significant variations in cell 
quantity was observed, indicating a slow adaptation period (lag phase), when cellular metabolism 
is more linked to the production of extracellular matrix proteins than to cellular proliferation.  
Anchorage-dependent cells, like endodermal cells, directly or indirectly need substrata 
chemically similar to the extracellular matrix proper.  Starting day 3, an ascendant logarithmic 
phase was observed, indicating cell division was achieved.  Eventually, a plateau region was 
formed, indicating growth was arrested.  alamarBlue assay indicated that a combination of 
moderate seeding density and medium containing BME increased cell survival. 
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In accordance with alamarBlue, cell morphology and cell counting results confirmed the 
use of a moderate seeding density to enhance differentiation.  High plating densities (~6579 
cells/cm2) seemed to act directly on cell growth, which could be noted by the remarkable 
decrease of the specific proliferation rates, probably due to contact among cells caused by the 
faster occupation of the available surface when more cells were seeded [110].  Thus, at higher 
plating densities, increased cell-cell interaction causes a decline in proliferation, and potentially 
differentiation of ES-D3 cells.  On the other hand, at low plating densities (1645 cells/cm2), there 
was less cell-cell contact and minimal contact inhibition, yielding low cell numbers.  This 
indicates that differentiation needs an optimum paracrine cell-cell distance (but not over-
crowding), which in our case was obtained by a moderate seeding density of 3290 cells/cm2.  
These observations are in accordance with a study by Wiedmann-Al-Ahmad et al. that suggests 
the existence of a relation between available surface area and number of seeding cells, so that 
proliferation is enhanced [111].  These results suggest a potential role of cellular organization 
and available space, as determined by paracrine cell-cell distance, in differentiation of embryonic 
stem cells.  Our results are in agreement with a recent study by Lee et al. (2009) that uses 
micropatterning to direct human ES (hES) cell differentiation into the endoderm or mesoderm 
lineage.  By organizing cells into small colonies of about 200 µm, they were able to direct 
differentiation towards the definitive endoderm, whereas larger colonies of about 1200 µm 
caused mesodermal differentiation.  Further, they showed that smaller, endoderm-enriched 
colonies lead to greater primitive gut endoderm differentiation, whereas larger, mesoderm-
enriched colonies generate greater numbers of hematopoietic progenitors [101].  
One important finding of the seeding density experiments (cell counting and alamarBlue 
assay) was that under the same culture conditions, fold increase numbers using the two methods 
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did not correlate.  This discrepancy owes to the fact that alamarBlue assay is not a direct measure 
of cell density.  alamarBlue measures metabolic activity, which might be not be consistent under 
proliferating, differentiating, and apoptotic conditions.  An alternative would be to use a method 
of DNA labeling, BrdU (5-Bromo-2' deoxy-uridine) cell proliferation assay, wherein 
quantification is based upon the measurement of BrdU (an analog of the DNA nucleotide, 
thymidine) incorporation into newly synthesized DNA in actively proliferating cells [112].  
Thymidine can be detected by antibody staining.  BrdU assay is, thus, direct measure of cell 
density, and results from this assay might yield a more correlation in cell density numbers as 
compared with direct cell counting. 
Next, we optimized the cell culture medium that would promote the highest endodermal 
differentiation under our culture conditions.  One major controversial issue in the field of mES-
dervied endodermal differentiation is the specific role of Activin-A.  Activin-A, member of the 
TGF-β superfamily of proteins, is a known endoderm inducer [47,56,84,92,93].  Kubo et al. 
showed that the effect of Activin-A mediated differentiation of GFP-Bry (Green Fluorescent 
Protein tagged Brachyury-T) ES cells into definitive endoderm is lower at high serum levels 
(15% fetal calf serum [FCS]) [92].  Serum is used in mammalian cell culture because it supports 
proliferation, adhesion, and cell survival [91].  Fetal bovine serum (FBS) or fetal calf serum 
(FCS) are the two most commonly used sera.  While serum contains components that promote 
cell survival, these components, (and their levels) are unknown, and vary from batch to batch 
[91].  This leads to increased variability in spontaneous differentiation of ES cells.  Serum also 
contains factors that can promote both proliferation and differentiation of ES cells.  In addition, 
unknown growth factors in serum might interfere with exogenous growth factor signaling [91].  
To this end, Kubo et al. attempted reducing serum levels, or use of knockout serum replacements 
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(KSR) [92].  However, KSR cannot be considered serum-free as it contains unknown serum 
components.  Yasunaga et al. used mES cell line, E14tg2a-derived EB5 to establish ES-Gscgfp 
Sox17huCD25 cells [45].  They showed that these cells can be differentiated in chemically defined 
serum-free medium SFO3 (Sanko Junyaku) in the presence of Activin-A, into definitive 
endoderm cells.  Tada et al. used a EB5 derived ES-Gscgfp in serum-free medium (SFO3) in the 
presence of Activin-A to derive mesendodermal cells [47].  Gadue and colleagues showed that 
sustained Activin signaling stimulates endoderm commitment from the CD4-Foxa2+GFP-
Bry+ ES cell population in serum-free medium containing N2 and B27 supplements, and Activin-
A [56].  N2 and B27 supplements are chemically defined additives that were developed as serum 
substitutes for long-term viability and growth of hippocampal and embryonic neurons, as well as 
central nervous system [CNS] progenitor cells.  These studies show that presence of serum (FBS 
or FCS) in the differentiation medium interferes with Activin-A mediated endodermal 
differentiation, whereas serum replacement and serum-free culture conditions promote Activin-A 
mediated endodermal differentiation.  Hansson et al. cultured the same mES cells in serum-free 
conditions, and showed that Wnt3a signaling augments the development of Activin-A induced 
Sox17 expressing definitive endoderm [103].  Recently, Roszell et al. showed that a combination 
of Activin-A and Wnt3a at appropriate doses promoted greater endoderm yield than Activin-A 
alone in E14 cells cultured in serum-free medium [84].  Studies by Hansson et al. and Roszell et 
al. show that Wnt3a augments Activin-A mediated endoderm formation.  In contrast to all these 
studies, two studies using the mES cell line, ES-D3, show that Activin-A does not show 
significant effect on the expression of Foxa2 and Sox17.  Nakanishi et al., using a chemically 
defined serum-free medium supplemented with insulin, transferring, BSA, and either Wnt3a or 
Activin-A, show that Activin-A does not have significant effect on the expression of endodermal 
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markers (Foxa2 and Sox17) in ES-D3 cells, as compared to Wnt3a (1300-fold and 8-fold higher 
expression of Foxa2 and Sox17 respectively) [102].  Their finding refutes the argument that 
specific growth factors and hormones present in serum have inhibitory effects on Activin-A-
dependent induction of endoderm.  Infact, they suggested that unknown factors derived from 
serum or serum replacements may be required for endoderm induction by Activin [102].  While 
this may be true, recently, Yarmush and colleagues have shown that Activin-A does not have a 
significant effect on endodermal expression in a simple serum (10% FBS) supplemented 
medium, when compared to follistatin, an Activin-A inhibitor [57].  Endodermal expression is 
significantly higher in ES-D3 cells treated with follistatin, as compared to Activin-A.  It may be 
possible that follistatin is a downstream regulator of the Wnt pathway.  Together, these recent 
studies show that, in both serum-supplemented and serum- free culture conditions, 
Wnt3a/follistatin significantly augment endodermal differentiation of mES cells, as compared to 
Activin-A.  Our results, in agreement with the above mentioned, show that serum-supplemented 
medium without Activin-A shows higher expression of Foxa2 expressing-endoderm, as 
compared to medium supplemented with Activin-A (under 21% O2).  In particular, we found that 
serum concentration affects endodermal production.  Low serum levels (2%) do not promote cell 
survival, whereas lowering serum concentration from 10% to 5% enhances production of Foxa2-
expressing endoderm.  It can be postulated that lowering serum levels allows for better cell-cell 
interaction. 
While it is established that, in the mouse system, Activin/nodal signaling is not required 
to maintain pluripotency of ES cells (study conducted using mouse blastocyst cultures) [113], it 
was recently shown that endogenously activated autocrine loops of Activin-Nodal signaling 
promote ES cell self-renewal in serum-free cultured MGZ5 cells (derived from CCE, a mES cell 
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line) [114].  Another study by Carter and colleages indicates that the presence of Activin-A in 
serum-supplemented medium (15% FBS) promotes increased expression of the endodermal 
marker genes suggesting that presence of Activin-A has the same endoderm inducing effect in 
the CCE cell line as those used in the literature [115].  Roche and colleagues have shown that 
monolayer cultures of differentiated mES cells (R1 cell line) cultured in simple serum-
supplemented medium (no Activin-A) do not show presence of endodermal markers, but show 
presence of ectodermal markers [116].  Another study by Sulzbacher and colleagues shows that 
Activin-A mediated definitive endoderm production of R1 cells was successful in the presence of 
serum (15% FCS) and BSA [90].  The role of Activin/nodal signaling in ES cells remains 
controversial.  Collectively, results from previous studies as well as ours, advise the systematic 
standardization and optimization of cell-type specific culture conditions in ES cell differentiation 
experiments. 
Our experiments, in optimizing differentiation medium, showed that medium containing 
5% serum and 0.1mM BME is optimum for our culture conditions.  Medium with BME led to 
significantly high endoderm production, as compared to medium without BME.  We found that 
the presence of anti-oxidant promoted higher cell-survival, and hence led to higher 
differentiation.  In spite of the presence of BME in the optimized medium, some floating cells 
were still observed indicating that a proper balance between apoptotic and survival signals might 
be an integrated part of cell commitment programs [104].   
Further, this work also investigated the effect of varying oxygen levels on endodermal 
differentiation of ES-D3 cells under optimized culture conditions that were thought to promote 
enhanced endodermal differentiation.  However, contrary to our expectations, reduced oxygen 
tension suppressed endodermal differentiation of ES-D3 cells under our culture conditions, as 
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compared to normal oxygen levels, in both media, with and without BME.   For medium without 
BME, the above finding can be attributed to the fact that very few cells survived under reduced 
oxygen levels (3, 8 % O2).  Consequently, mRNA levels were low, as assessed by Q-PCR.  For 
medium containing BME, this finding can be attributed to the role of HIF-1a in embryonic stem 
cell differentiation, as decrease in ROS due to BME scavenging could lead to (1) a decrease in 
HIF-1a expression, and (2) blockage of certain apoptotic pathways, both of which directly have 
an impact on activation of endoderm-committed genes [104]. 
A study by Duval et al. highlights a very important finding that two mesoderm-
commitment programs co-exist under apoptosis blocked conditions: (1) a Wnt/lef1/brachyury-
dependent program, and (2) a Brachyury-independent program, respectively [104].  These 
programs may be repressed and induced, respectively, when apoptosis is blocked.  Duval and 
colleagues have shown that in the presence of p38 inhibitor, PD169316 (referred to as PD), 
expression of primitive streak marker, Brachyury-T is repressed [104].  P38 mitogen-activated 
protein kinases (p38 MAPK) are a class of mitogen-activated protein kinases that are responsive 
to stress stimuli, such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock, and are 
involved in cell differentiation and apoptosis.  P38 inhibitors like PD block the activity of p38, 
thereby blocking apoptotic pathways.  Microarray analyses revealed PD-dependent repression of 
(1) lef1, a Wnt pathway-induced transcription factor required for the maintenance of Brachyury 
expression during gastrulation, and of (2) axis symmetry regulating genes (nodal; Tdgf1 and 
lefty1 genes) of a TGF-related pathway.  Endodermal specification is downstream of PS 
specification and egression, and hence a decrease in PS marker Brachyury could lead to less 
endoderm production.  In addition, PD also induces a subset of mesodermal lineage genes known 
to be critical for chondrocyte, osteoblast and myoblast differentiation [81,104].   
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Both P38-inhibitor and anti-oxidants work towards reducing ROS, and block apoptotic 
pathways [79,81].  Thus, BME might be functioning like PD, indicating that our system might 
reduce endodermal differentiation, and induce higher mesodermal differentiation.  Ideally, this 
can be proved by doing a control study with no BME.  In our case, very few cells survived in 
medium without BME, making comparison of results very difficult.  It may be true that our 
system promotes higher mesodermal differentiation, as opposed to endoderm, but this would 
need to be quantified using immunofluorescence.   
Our results show that, at 10% serum concentration, Sox17 mRNA levels do not show a 
significant difference (P < 0.05) between medium with and without BME at 21% and 8% O2, 
indicating that BME does not play a significant role along with a combination of 10% serum.  
However, at an oxygen concentration of 3%, 10% serum along with BME shows a 10-fold 
increase in Sox17-expressing endoderm cells, as compared to no BME control (P < 0.05), 
indicating the role of BME in cell survival at 3% O2.  DMEM 5% FBS with BME promotes 
higher endodermal differentiation for our culture conditions, as compared with no BME control, 
under both normoxic and hypoxic conditions (P < 0.05).  This, once again, proves that BME 
promotes cell survival of differentiating ES cells.  Expression of endoderm markers Sox17 and 
Foxa2 was 20-fold higher under normoxic oxygen levels, as opposed to physiologic oxygen 
levels (P < 0.05).  A combination of 5% FBS, 0.1mM BME, and 21% O2 might be optimum 
owing to an optimum balance between apoptosis and differentiation under these conditions 
[104]. 
For the experiments with mES cells and varying oxygen levels, we focused on enhancing 
differentiation by subjecting the cells to low oxygen levels during the early embryonic phase of 
lung development (E9.0-E12.0 in mice).  However, all evidence supporting our hypothesis, 
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shows that low oxygen levels enhance the branching morphogenesis phase of lung development 
which is seen much later during development (E12.0-E16.5 in mice).  In addition, initially, the 
implantation embryo at the stage of early gastrulation, when the germ layers are being formed, is 
a small structure within the egg.  Contrary to our hypothesis, oxygen availability, at this stage of 
development might not be as limited.  However, as the cells divide and organs start budding from 
the gut tube, oxygen availability might be limited due more area being occupied within the egg.  
One alternative, therefore, could be to first differentiate these cells at higher oxygen levels (12-
15 % or even normoxia), and then differentiate them under physiologic settings for the later 
stages of development (post definitive endoderm, or even formation of alveolar forming units 
[AFU]). 
 Phase-contrast imaging also revealed the presence of a mixed cell population in our 
culture.  In particular, four distinct morphologies were identified – epithelial-like, endothelial-
like, mesenchymal-like, and fibroblast-like.  This indicates that serum-supplemented 
spontaneous differentiation of ES-D3 cells is mainly, into the endoderm and mesoderm lineages, 
as assessed by phase-contrast micrographs and immunofluorescence.  This mixed population of 
cells showing both endodermal and mesodermal lineages can prove useful, as the mature lung is 
a complex organ comprised of >40 different cell types, and consists of tissue derived from all 
three germ layers [1].  However, the ultimate trial will be to assess the capability of the ensuing 
mixed cell population to form AFUs.  
One big caveat with these experiments is that these results are specific for the ES-D3 cell 
line in serum-supplemented conditions.  Most pioneering work in the field of murine endoderm 
differentiation has been done using serum-free or serum-replacement conditions using other mES 
cell lines (E14 [45,84,92], and CCE [114-116].  Serum supplemented studies with mES cells 
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have been conducted using CCE [115], and R1 [116]cells.  mES cell lines like E14, CCE, R112, 
thus, exhibit a marked tendency to differentiate into the endoderm lineage in the presence of 
Activin-A.  However, it is of immense surprise, that ES-D3 cells, under our culture conditions, 
do not respond to Activin-A mediated differentiation, even though Activin-A has been shown to 
promote endodermal differentiation in other cell types.  This is true for both, serum-
supplemented (as confirmed by our results and those of Yarmush and colleagues [57]as well as 
chemically defined serum-free cultures [102].  We believe that behavior of ES-D3 cells in 
response to Activin-A is cell-type specific.  Another possible explanation includes variable 
epigenetic status among mES cell lines.  Recently, Osafune et al. compared 17 hES cell lines, 
and established that some of these cell lines show a marked propensity to differentiate into 
specific lineages (often with > 100 fold differences in lineage specific gene expression).  
Osafune pointed out that substantial differences among hES cell lines in gene expression are not 
evident in the undifferentiated state but appear when cells differentiate [117].  In particular, they 
found differences between two different hES cell lines, HUES 8 and HUES 6, in generating 
endodermal cell types during spontaneous embryoid body formation and during directed 
differentiation were statistically significant [117].  These findings underscore the importance of 
thoroughly screening cell lines by performing karyotype analyses, in addition to gene profiling.  
Further, they emphasize the importance of deriving lines for lineage-specific differentiation. 
Another possible explanation for discrepancies in Activin-A mediated endodermal 
differentiation includes differences in the induction methods used.  Cell-cell interactions 
consisting of diffusible signaling and cell-cell contact (juxtacrine signaling) are important in 
 
12 Differentiation potential of R1 cells into endoderm is controversial, as discussed under the earlier sections under 
“Discussion”. 
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numerous biological processes such as tumor growth, stem cell differentiation, and stem cell 
self-renewal.  Variability in reproducibility in ES cell differentiation can be attributed to changes 
in culture conditions.  ES cell culture is extremely sensitive to slight changes in culture 
conditions (different seeding densities, different media, batch-batch variation in serum, embryoid 
bodies versus monolayer seeding), and thus cannot reproducibly prescribe the local 
microenvironment.  The random nature of cell seeding, both in our studies as well as others 
discussed in this thesis, results in considerable variation in the actual paracrine cell-cell spacing, 
amount of cell-cell interaction/contact.  Cells, thus, proliferate/ differentiate differently, due to 
the differences in concentrations of cells, cellular co-operativity, as well as serum-mediated 
variation in diffusible growth factor signaling (differential dose responses that lead to differential 
receptor occupancy).   
Based on recent evidence in human and mouse ES cells, (1) a detailed knowledge of the 
mechanisms, and the activity of differentiation factors and signaling molecules and their cellular 
interactions, and (2) standardization of culture conditions, for every ES cell-line are, therefore, 
indispensable. 
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CHAPTER 6: SUMMARY  
In summary, this thesis work, specific for murine embryonic stem cell line ES-D3, 
demonstrated that  
1. An endoderm-like cell population can be induced by 2-D culture on fibronectin-collagen 
I plated surface, without the use of expensive growth factors, complex serum-free 
medium, or serial cell sorting, which were previously thought to be essential for 
endoderm induction [45,57]. 
2. By comparing cell proliferation profiles and endoderm-specific mRNA expression of ES-
derived differentiated cells grown in the absence or in the presence of beta-
mercaptoethanol, an optimum culture system consisting of (a) a cell plating density of 
approximately 2632 cells/ cm2 (corresponding to 12000 cells/well in a routine 12-well 
tissue culture plate), and (b) a simple serum supplemented differentiation medium 
consisting of 5% fetal bovine serum and 0.1mM BME under 21% O2, induces maximum 
endoderm production, 
3. In spite of (1) recapitulating the embryonic microenvironment by culturing cells under 
reduced oxygen levels and (2) the presence of anti-oxidant BME in differentiation 
medium to compensate for increased apoptosis under reduced oxygen levels [79], 
endodermal differentiation was not enhanced at low oxygen levels, as compared to 
normoxic controls, 
4. At 5% serum concentration, BME-supplemented medium enhanced cell survival more 
than that without BME at all oxygen levels, 
5. For differentiation under optimized conditions (21% O2), temporal gene expression 
profile revealed that mRNA expression of endodermal markers Foxa2 and Sox17 
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increases over time, whereas mRNA expression of pluripotency marker decreases over 
time, and  
6. Spontaneous differentiation of ES-D3 cells in simple, serum-supplemented medium 
consists of a mixed population of endothelial and epithelial cells (confirmed by the 
presence of pan-cytokeratin and isolectin-B4), which might prove useful for generation of 
alveolar forming units/ lung tissue. 
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CHAPTER 7: CONCLUSION 
 
In conclusion, reduced oxygen (1%, 3%, and 8% O2) suppresses endodermal 
differentiation of ES-D3 cells in serum-supplemented medium.  On the contrary, anti-oxidants 
enhance cell survival under both, normoxic and hypoxic (3% O2) conditions.  A combination of 
reduced oxygen tension and anti-oxidants does not enhance endodermal differentiation, as 
compared to normoxic controls.   
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APPENDICES 
 
 
9.1 APPENDIX A 
Appendix A attempts to summarize preliminary work performed to optimize ES cell culture.   
ES-D3 cells frozen by Blair Roszell (P7 and P19) were maintained in serum-free 
maintenance medium (referred to ES-MM1) containing 50/50 (v/v) mixture of Neurobasal media 
(Invitrogen, Carlsbad, CA) and DMEM/F12 media (Invitrogen) supplemented with 0.5X of both 
N2 and B27 supplements (Invitrogen), 50 U/ml penicillin, 50 μg/ml streptomycin (Invitrogen), 
0.05% BSA (Sigma), leukemia inhibitory factor 1000 U/ml (Millipore), human bone 
morphogenic protein 4 (10 ng/ml; R & D Systems, Minneapolis, MN), 1.5 *104 M 1-thioglycerol 
(Sigma), and 0.1mM β-mercaptoethanol.   
To induce differentiation in 2-D culture, ESCs were seeded at a density of 1.5*105 cells/ml 
on collagen IV coated 6-well plates (25 ng/ml in 0.1M HCl).  Differentiation medium consisted 
of 75% (v/v) Iscove's modified Dulbecco's medium (Invitrogen) and 25% (v/v) Ham's F12 
medium (Invitrogen) supplemented with 0.5X of both N2 and B27(without retinoic acid) 
supplements (Invitrogen), 50 U/ml penicillin, 50 μg/ml streptomycin, 0.05% BSA, 2 mM 
glutamine (Invitrogen), 0.5 mM ascorbic acid (Sigma) and 4.5 10 4 M 1-thioglycerol (Sigma), 
and 20ng/mL of Activin-A.   
Cells were expanded until P30 in ES-MM1.  However, at higher passages, undifferentiated 
cells started losing their island-like morphology, and started displaying more differentiated 
morphology, maybe due to senescence.   
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Due to the lack of multiple frozen vials of these cells at lower passages, a new vial of ES-
D3 cells was purchased from ATCC.  This new vial was maintained in serum-supplemented 
conditions, per manufacturer’s protocol.  This new maintenance medium (referred to as ES-
MM2) consisted of Dulbecco's modified Eagle's medium (DMEM) (4.5 g/L) supplemented with 
10% fetal bovine serum, 0.5% penicillin/ streptomycin (100 U/ml), ESGRO (1,000 U/ml), and 2-
mercaptoethanol (0.1 mM).  Cells were expanded and multiple vials were frozen at each passage, 
for later use.  While ES-MM2 promoted ES self-renewal, we attempted to maintain these cells in 
serum-free medium that was used earlier to eliminate the effect of unknown growth factors in 
serum on ES cell differentiation. 
To our surprise, cells did not survive in this medium, and a high number of floating cells 
were observed, even under maintenance conditions.  We supplemented ES-MM1 with low serum 
levels (~2%), and still noticed similar outcomes.  Next, we attempted serum-replacement 
adaptation of these cells.  We used the following protocol (Invitrogen), to adapt cells to serum-
free maintenance medium (SFM/SF-MM) containing Knockout-DMEM, 15% Knockout Serum 
Replacement, 0.5% penicillin/ streptomycin (100 U/ml), 0.1 mM non-essential acids, 2mM L-
glutamine, 10uM 2-mercaptoethanol, and ESGRO (1,000 U/ml).   
First, we first used a direct adaptation method, where cells are directly switched from 
serum-supplemented medium into SF-MM.  For direct adaptation, the cell inoculum was 2.5 × 
105 to 3.5 × 105 cells/ml. Cells were subcultured cells when the cell density was 1 × 106 - 3 × 106 
cells/ml.  Once again, we noticed presence of a high number of floating cells, and less cell 
survival.  We believe that directly switching from serum to serum-replacement medium might 
have shocked the cells.  Consequently, we used adapted a sequential adaptation method, where 
cells are switched from serum-supplemented medium into SF-MM in several steps, as follows: 
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Figure 9.1-1: Steps involved in sequential adaptation method, from serum-supplemented to serum-
free medium (Adaptation of Cell Cultures to a Serum-Free Medium, Invitrogen). 
Under this adaptation method, we had trouble getting cells past a certain step even before 
going 100% SFM.  Therefore, we went back and passaged the cells 2–3 times in the previous 
ratio of serum-supplemented media to serum-free media.  In spite of this, we had trouble getting 
cells to 100% SF-MM.   
Next, we tried adapting cells to SFM right before differentiating them.  One day prior to 
the experiment, ES cells in ES-MM were switched SFM.  This process of maintaining cells in 
ES-MM, and switching them to SFM 24 hours prior to experiment, is referred to as SF-MM.  
Cells survived, and maintained island-like morphology, as well as showed high levels of Oct-4 
expression.  Figure 9.1-2 below compares gene expression of pluripotency marker, Oct-4, as well 
as endodermal markers, Foxa2 and Sox17.   
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Figure 9.1-2:  Comparison of Oct-4, FoxA2, and Sox17 gene expression on day 6 upon LIF 
withdrawal, for ES-D3 cells maintained in ES-MM2 versus ES-MM2+SF-MM, as described above.  
For both conditions (blue and red), ES-D3 cells were maintained in ES-MM.  In one condition (red), 
medium was switched from ES-MM2 to SF-MM, 24 hours prior to plating cells in differentiating 
medium (DMEM 10% FBS with BME).  Cells were differentiated for 6 days, and Q-PCR was 
performed for Oct-4, Foxa2, and Sox17 on day 6.  Endoderm production post maintenance in ES-
MM2+SF-MM is significantly higher than that in ES-MM2 alone (*P <0.05).  Data is represented as 
mean ± SD of three independent experiments, with one measurement (= sample pooled from two 
wells) per experiment, and duplicate readings for Q-PCR per measurement.   
Endoderm production post maintenance in ES-MM2+SF-MM was significantly higher 
than that in ES-MM2 alone (*P <0.05).  Therefore, we chose ES-MM2+SF-MM, as the optimum 
medium for ES-D3 maintenance.   
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Next, we attempted to optimize the ECM coating that would promote highest 
differentiation.  Four different conditions were compared: Collagen IV alone, 
Gelatin+Fibronectin, Collagen Type I+Fibronectin, and Collagen Type IV+Fibronectin.  Foxa2-
expressing endodermal production was assessed on days 0, 2, 4, and 6 in DMEM 10% FBS. 
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Figure 9.1-3:  Comparison of Foxa2 expression on different ECM coatings on day 6 in DMEM 10% 
FBS.  Foxa2 expression was highest in cells grown on Collagen type I/ fibronectin (**P < 0.01 as 
compared to other groups on day 6).  Gelatin/ fibronectin also showed high Foxa2 expression (*P < 
0.05 as compared to Collagen IV and Collagen IV/ fibronectin on day 6).  Data is represented as 
mean ± SD of one independent experiments, with one measurement (= sample pooled from two 
wells) per experiment, and duplicate readings for Q-PCR per measurement.   
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Next, we assessed temporal gene expression in two different ECM coatings: (1) Collagen 
I/Fibronectin, and (2) Collagen IV/Fibronectin and three different media (1) DMEM 10% FBS 
(referred as DMEM), (2) A549 conditioned media along with DMEM 10% FBS 50:50 (v/v) 
(referred as A549 conditioned medium), and (3) IMDM/DMEMF12, consisting of 75% (v/v) 
Iscove's modified Dulbecco's medium (Invitrogen) and 25% (v/v) Ham's F12 medium 
(Invitrogen) supplemented with 0.5X of both N2 and B27(without retinoic acid) supplements 
(Invitrogen), 50 U/ml penicillin, 50 μg/ml streptomycin, 0.05% BSA, 2 mM glutamine 
(Invitrogen), 0.5 mM ascorbic acid (Sigma) and 4.5 10 4 M 1-thioglycerol (Sigma), and 
20ng/mL of Activin-A.  Figure 9.1-3 displays Q-PCR results for this study. 
A549 conditioned medium along with Collagen I/Fibronectin showed the highest Foxa2 
expression, however the best trend over 6 days was observed in DMEM ColI/Fibronectin.  A549 
medium showed a strange differentiation trend.  In addition, Col I/Fibronectin promoted higher 
differentiation in DMEM and IMDM/DMEMF12 media, as compared to ColIV/Fibronectin.  In 
addition, DMEM ColI/Fibronectin also promoted a favorable biphasic differentiation trend under 
both normoxic and reduced oxygen levels.    
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Figure 9.1-4:  Q-PCR results for Fold Increase in Oct-4 (blue), Foxa2 (red), and Sox17 (green) 
expression in 3 different media (1) DMEM, (2) A549 conditioned media, and (3) 
IMDM/DMEMF12.  Experiments were run for 6 days; mRNA levels were evaluated at the 
following time points: d0, d2, d4, and d6.  DMEM ColI/Fibronectin showed the best differentiation 
trend over 6 days.  Data is represented as mean of one independent experiment, with one 
measurement (= sample pooled from two wells) per experiment, and duplicate readings for Q-PCR 
per measurement.   
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In addition, our preliminary results also showed that DMEM 10% FBS promotes higher 
endodermal differentiation, as compared to IMDM/DMEMF12 medium containing Activin-A 
(Figure 9.1-4). 
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Figure 9.1-5:  Q-PCR results for Fold Increase in Foxa2 expression in 3 different media under two 
oxygen levels (1) Normoxia (21% O2), and (2) Hypoxia (8% O2).  Experiments were run for 4 days; 
mRNA levels were evaluated at the following time points: d0, d2, and d4.  Hypoxia showed higher 
endodermal differentiation, as compared to normoxia, in both media.  Under hypoxia conditions, 
medium containing FBS showed higher endodermal gene expression, as compared to Activin-A 
containing medium.  Data is represented as mean of one independent experiment, with one 
measurement (= sample pooled from two wells) per experiment, and duplicate readings for Q-PCR 
per measurement. 
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9.2 APPENDIX B: LIST OF ABBREVIATIONS   
The list below details all the acronyms used in this thesis. 
Abbreviations Full Form 
BrdU 5-Bromo-2' deoxy-uridine 
AE1 Alveolar Type I Cells 
AE2 Alveolar Type II Cells 
ATCC American Type Culture Collection 
ABI Applied Biosystems, Inc.  
bHLH-PAS Basic-helix-lop-helix-Per-Arnt-Sim 
BME Beta-mercaptoethanol 
BMP Bone Morphogenetic Protein 
BSA Bovine Serum Albumin 
BPD Bronchopulmonary Dysplasia 
CNS Central Nervous System 
cDNA  complementary DNA 
CT Cycle threshold 
DAPI diamidino-2-phenylindole, dilactate  
DEPC diethyl pyrocarbonate 
DMEM Dulbecco's modified Eagle's medium  
ECD E-cadherin  
E Embryonic day 
ES Embryonic Stem 
EMT Epithelial-to-Mesenchymal Transition 
ERK Extracellular Regulated Kinase 
ES-MM ES-Maintenance Medium 
ECM Extra Cellular Matrix 
FBS Fetal Bovine Serum  
FCS Fetal Calf Serum 
FGF Fibroblast Growth Factor 
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FACS Fluorescence-activated Cell Sorting  
Gsc Goosecoid 
GFP-Bry  Green Fluorescent Protein tagged Brachyury-T 
HIF Hypoxia Inducible Factor 
HMG High Mobility Group 
hES Human Embryonic Stem 
IC Immunocytochemistry 
JAK Janus-associated tyrosine kinasis 
KSR Knockout Serum Replacement 
LIF Leukemia Inhibitory Factor 
MAPK Mitogen-Activated Protein Kinase 
mES Murine Embryonic Stem  
PD p38 inhibitor, PD169316  
p38 MAPK P38 mitogen-activated protein kinases 
PRD Paired homeobox gene 
PFA Para-formaldehyde 
PPIA Peptidyl-Prolyl Isomerase A  
PBS Phosphate-Buffered Saline  
PN Postnatal day 
PS Primitive Streak 
PCR Polymerase Chain Reaction 
Q-PCR Quantitative Real Time Polymerase Chain Reaction 
ROS Reactive Oxygen Species 
RQ Relative Quantification 
RT Reverse Transcriptase  
SF-MM Serum Replacement Medium 
SRY Sex Determining Region Y 
SH2 SRC Homology 2 
VEGF Vascular Endothelial Growth Factor 
VEGFR Vascular Endothelial Growth Factor Receptor 
 
 
 
 
